No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
4187 |
4. Check minimum number of eventsNone |
4187 |
5. Include endpointsNone |
4187 |
6. Filter based on genotype QC (FinnGen only) |
4187 |
Control definitions (FinnGen only)
- Control exclude
- AB1_VIRAL_SKIN_MUCOUS_MEMBRANE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Viral warts
based on the number of shared cases.
Similar with more cases:
- Viral infections characterized by skin and mucous membrane lesions
- Certain infectious and parasitic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 32087 | 17465 | 14527 |
| Only index persons | 29396 | 16155 | 13241 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.46 | 0.50 | 0.41 |
| Only index persons | 0.55 | 0.59 | 0.51 |
| Median age at first event (years) | |||
| Whole population | 29.73 | 31.02 | 28.13 |
| Only index persons | 31.93 | 33.28 | 30.29 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4187 | 2564 | 1623 |
| Unadjusted period prevalence (%) | 0.81 | 0.87 | 0.72 |
| Median age at first event (years) | 43.82 | 40.53 | 49.03 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3785
- Matched controls
- 37848
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B07.9
ICD-10 Finland
Verruca simplex
1095.4
323.0
3366
283
ZXC50
NOMESCO Finland
Cryotherapy
17.4
262.6
428
276
127
Kela drug reimbursment
Transplant complication
21.3
217.2
328
168
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
5.5
203.8
669
1422
L04AD01
ATC
ciclosporin; systemic
16.3
188.8
314
209
QDA50
NOMESCO Finland
Cryotherapy of skin of lower limb
1970.5
184.8
178
*
L84
ICD-10 Finland
Corns and callosities
9.9
179.4
378
418
L04AA01
ATC
[U] ciclosporin; systemic
21.1
179.3
271
138
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
13.3
177.4
321
261
B07
ICD-10 Finland
Viral warts
30.8
175.3
237
82
Z94.0
ICD-10 Finland
Kidney transplant status
23.2
169.3
248
114
L04AX01
ATC
azathioprine; systemic
7.1
168.6
439
682
L04AA06
ATC
mycophenolic acid; systemic
14.9
164.4
283
204
D06BB10
ATC
imiquimod; topical
6.7
161.9
441
728
QDA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of lower limb
110.0
136.1
148
14
B07.80
ICD-10 Finland
Verruca vulgaris in the mouth
349.4
135.6
136
*
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
11.9
129.9
247
221
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
53.8
125.2
150
29
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
11.6
116.1
223
203
TQW99
NOMESCO Finland
Other minor procedure on skin
5.7
111.9
341
641
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
25.7
111.7
158
64
L57.0
ICD-10 Finland
Actinic keratosis
4.3
110.7
447
1139
0781A
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[VERRUCA VULGARIS]
+∞
109.9
105
*
H02AB04
ATC
methylprednisolone; systemic
3.1
109.8
713
2668
A12AA04
ATC
calcium carbonate; oral
13.8
106.8
189
144
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
10.1
106.4
219
228
QCA50
NOMESCO Finland
Cryotherapy of skin of upper limb
140.2
102.6
109
8
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
18.7
99.6
156
87
QXA50
NOMESCO Finland
Skin cryotherapy, unspecified location
20.8
99.4
150
75
TQW80
NOMESCO Finland
Local dermatologic skincare
8.0
97.7
232
308
137
Kela drug reimbursment
Uraemia requiring dialysis
18.9
91.1
142
78
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
28.2
89.4
123
45
A11CC03
ATC
alfacalcidol; systemic
8.5
88.3
201
249
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
14.9
86.4
147
102
E0000UV
ATC
NA
2.0
80.3
1625
10475
S03
ICPC
Warts
7.4
78.9
196
278
B03XA01
ATC
erythropoietin; parenteral
19.4
76.1
117
62
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.9
75.8
334
911
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.7
72.2
343
996
L82
ICD-10 Finland
Seborrhoeic keratosis
2.6
71.0
612
2660
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
67.4
592
2592
XQ848
NOMESCO Finland
Dermatological photography
6.4
66.9
183
297
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
19.2
65.5
101
54
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
65.2
1477
9691
B05DA
ATC
Isotonic solutions
15.4
61.0
102
68
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
60.1
1023
6015
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.0
58.0
357
1253
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
57.8
1051
6317
TK800
NOMESCO Finland
Hemodialysis
6.6
57.4
153
240
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.3
57.3
110
100
CBB30
NOMESCO Finland
Excision of lesion of eyelid
5.6
56.7
172
318
Z49.1
ICD-10 Finland
Extracorporeal dialysis
9.2
56.6
121
135
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
4.1
55.0
224
566
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.5
54.9
277
840
QAA50
NOMESCO Finland
Cryotherapy of skin of head or neck
12.5
54.3
99
81
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.0
54.2
331
1154
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
8.6
53.8
120
144
C03CA01
ATC
furosemide; systemic
2.0
53.8
777
4256
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
9.7
53.1
110
116
7151
FHL
Kidney transplantation
113.7
51.9
56
5
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.4
50.9
195
465
H02AB06
ATC
prednisolone; systemic
1.7
50.5
1611
11493
B05DB
ATC
Hypertonic solutions
15.7
50.2
83
54
N18.8
ICD-10 Finland
Other chronic renal failure
5.9
50.0
145
254
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
49.7
654
3431
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.4
49.4
259
808
B03XA02
ATC
darbepoetin alfa; parenteral
7.4
48.4
118
163
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
20.6
47.5
71
35
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.1
46.8
194
498
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
46.8
458
2096
J01MA02
ATC
ciprofloxacin; systemic
1.7
45.4
1278
8710
Z49.2
ICD-10 Finland
Other dialysis
12.1
44.5
82
69
L01BB01
ATC
NA
42.9
44.5
55
13
ZXC10
NOMESCO Finland
Use of laser
5.0
44.3
148
306
N18.0
ICD-10 Finland
End-stage renal disease
9.2
44.3
94
104
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
23.7
44.1
63
27
D02AE01
ATC
carbamide; topical
2.8
44.0
312
1193
ZX120
NOMESCO Finland
Intravenous
2.6
44.0
359
1490
QCA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of upper limb
63.3
43.2
50
8
S18
ICPC
Laceration/cut
1.7
43.2
1400
9892
SPAT1153
SPAT
Removal of sutures
1.7
43.2
1077
7057
Z94.4
ICD-10 Finland
Liver transplant status
21.0
43.1
64
31
XQ845
NOMESCO Finland
Dermatoscopy
8.0
42.7
99
127
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
4.9
42.6
144
302
E000001
ATC
NA
1.8
42.2
818
4937
UJF32
NOMESCO Finland
Coloscopy
1.8
41.6
831
5063
J01DA01
ATC
[U] cefalexin; systemic
1.6
41.4
2195
17566
A10AA01
ATC
NA
4.3
41.3
160
386
B02.9
ICD-10 Finland
Zoster without complication
3.8
41.0
182
496
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.9
41.0
138
288
R50.9
ICD-10 Finland
Fever, unspecified
2.1
41.0
544
2847
H04AA01
ATC
glucagon; nasal, parenteral
3.9
40.4
172
452
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.0
40.4
551
2913
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
40.3
1017
6661
J02AC01
ATC
fluconazole; systemic
1.6
40.3
1414
10155
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
4.2
40.2
158
386
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.4
40.2
383
1723
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.9
40.0
666
3799
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.2
40.0
222
722
M05BA04
ATC
alendronic acid; oral
2.8
39.4
277
1052
C08CA02
ATC
felodipine; oral
2.6
38.8
298
1193
R4180
NOMESCO Finland
Podiatric therapy
9.4
38.6
81
88
J01DB01
ATC
cefalexin; oral
1.7
37.5
3001
26312
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
37.4
699
4146
KA1AE
NOMESCO Finland
Kidney ultrasound examination
4.8
37.4
129
277
A10AE05
ATC
insulin detemir; parenteral
2.9
37.3
244
884
D07AC01
ATC
betamethasone; topical
1.6
37.2
1154
7980
H02AB09
ATC
hydrocortisone; systemic
4.4
36.9
140
331
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
36.9
234
834
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
36.8
305
1274
WW200
NOMESCO Finland
Immunization
3.9
36.6
155
406
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
36.3
762
4688
205
Kela drug reimbursment
Chronic hypertension
1.8
36.2
736
4484
K06.18
ICD-10 Finland
Another gingival hyperplasia
20.3
36.1
54
27
A10AA02
ATC
NA
3.7
36.0
162
447
Z94.1
ICD-10 Finland
Heart transplant status
21.5
34.8
51
24
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
34.4
1512
11353
QBA50
NOMESCO Finland
Cryotherapy of skin of trunk
20.7
34.3
51
25
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
34.3
642
3797
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.4
34.2
105
198
T89
ICPC
Diabetes insulin dependent
3.1
34.1
200
674
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
14.8
34.0
57
39
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
9.2
34.0
72
80
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
7.6
33.7
80
107
ZXA00
NOMESCO Finland
Right side
1.7
33.7
850
5517
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.1
32.8
398
1994
RJ412
NOMESCO Finland
NA
31.0
32.5
43
14
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
4.4
32.5
122
286
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
32.1
182
599
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.5
32.1
270
1136
J01FF01
ATC
clindamycin; systemic
1.6
32.1
925
6218
V03AE01
ATC
polystyrene sulfonate; oral
7.4
31.4
76
105
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.9
31.3
205
743
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
31.2
321
1495
A07AA02
ATC
nystatin; oral
2.7
30.8
223
862
J05AB01
ATC
aciclovir; systemic
1.7
30.8
688
4294
ZQZ00
NOMESCO Finland
Treatment of several skin areas
14.2
30.6
52
37
V03AE02
ATC
sevelamer; oral
13.0
30.6
54
42
H26.3
ICD-10 Finland
Drug-induced cataract
9.8
30.6
62
64
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.3
30.5
160
500
RJ411
NOMESCO Finland
NA
12.8
29.8
53
42
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
6.9
29.6
75
111
Z49.0
ICD-10 Finland
Preparatory care for dialysis
7.6
29.5
70
94
E000002
ATC
NA
1.9
29.5
455
2505
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.1
29.4
169
563
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
29.1
749
4860
J05AB11
ATC
valaciclovir; oral
2.0
29.0
415
2219
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
28.9
1065
7590
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
28.8
1175
8573
Z2446
NOMESCO Finland
Social worker
2.3
28.7
286
1308
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
8.0
28.5
65
82
TK820
NOMESCO Finland
Peritoneal dialysis
12.6
28.5
51
41
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
11.2
28.5
54
49
A02BC01
ATC
omeprazole; systemic
1.6
28.4
869
5905
5AB14
NOMESCO Finland
NA
23.8
28.3
40
17
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
6.1
28.2
78
130
0781B
ICD-9 Finland
Other diseases due to viruses and Chlamydiae, Viral warts[VERRUCA PLANA]
+∞
28.2
27
*
Z3231
NOMESCO Finland
Registered nurse
1.6
28.0
929
6440
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
27.4
28.0
38
14
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
27.9
115
295
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
4.4
27.7
103
240
D07AC13
ATC
mometasone; topical
1.6
27.6
954
6676
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
27.6
1235
9185
N02AX02
ATC
tramadol; systemic, rectal
1.5
27.2
1283
9643
M79.6
ICD-10 Finland
Pain in limb
1.5
27.2
1158
8508
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
27.2
312
1524
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
27.1
309
1505
J01MA14
ATC
moxifloxacin; systemic
2.2
27.0
292
1387
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.9
26.9
166
580
D07XC01
ATC
betamethasone, combinations; topical
1.9
26.9
406
2214
R03AC02
ATC
salbutamol; inhalant
1.5
26.8
1824
14775
6112
FHL
Installation of a peritoneal dialysis or lavage catheter in an operating room
75.7
26.8
30
*
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.0
26.6
367
1931
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
26.3
577
3564
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
26.3
1197
8911
Z94.9
ICD-10 Finland
Transplanted organ and tissue status, unspecified
29.4
26.3
35
12
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
21.3
26.0
38
18
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
9.6
25.9
53
56
ZXD05
NOMESCO Finland
Urgent procedure
1.5
25.5
1042
7557
N02BE01
ATC
paracetamol; systemic, rectal
1.5
25.4
2962
26599
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
12.6
25.3
45
36
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
25.1
647
4181
A10AE04
ATC
insulin glargine; parenteral
2.1
25.1
304
1518
J01MA12
ATC
levofloxacin; systemic
1.7
25.0
544
3347
C08CA05
ATC
nifedipine; systemic
2.5
25.0
201
824
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.9
24.9
377
2056
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
6.9
24.7
62
91
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
8.7
24.5
53
62
A02BC03
ATC
lansoprazole; oral
1.6
24.3
860
6021
L04AA05
ATC
[U] tacrolimus; systemic
34.7
24.3
31
9
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
24.2
202
844
J01FA06
ATC
roxithromycin; oral
1.5
24.2
1292
9901
D07AB08
ATC
desonide; topical
1.9
24.2
379
2092
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
24.1
192
781
D07AD01
ATC
clobetasol; topical
1.8
24.1
495
2988
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
24.0
300
1516
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.6
24.0
111
316
SPAT1147
SPAT
Destruction of skin lesion with external methods
4.2
23.9
93
227
C08CA01
ATC
amlodipine; oral
1.5
23.9
915
6520
J01AA02
ATC
doxycycline; systemic
1.4
23.9
2557
22360
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
23.8
1493
11799
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
5.6
23.6
70
128
9733
FHL
Excision of skin change in operating room or anesthesia
4.9
23.6
78
162
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
23.5
2424
21007
E000006
ATC
NA
2.2
23.5
261
1257
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
6.1
23.4
64
106
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
23.3
956
6914
Z3226
NOMESCO Finland
Physiotherapist
1.6
23.3
608
3938
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
23.1
169
657
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.9
23.1
385
2170
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
23.1
568
3616
D06BB04
ATC
podophyllotoxin; topical
2.2
23.1
236
1093
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
23.0
582
3734
196
Kela drug reimbursment
Paricalcitol and cinacalcet
11.8
22.9
42
36
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
22.7
679
4554
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
17.7
22.6
35
20
SPAT1301
SPAT
No procedures
1.5
22.6
1051
7803
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
22.5
1460
11580
J01CA04
ATC
amoxicillin; systemic
1.5
22.5
2988
27077
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
22.4
271
1351
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
32.5
22.4
29
9
C07AB02
ATC
metoprolol; systemic
1.7
22.3
528
3324
L20.0
ICD-10 Finland
Besnier prurigo
2.0
22.2
299
1555
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
3.0
22.1
130
442
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
22.1
292
1509
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
22.1
612
4019
SPAT1325
SPAT
Vaccination
1.5
22.0
1096
8243
SPAT1262
SPAT
Handing over of treatment supplies
1.7
21.9
532
3371
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
10.1
21.8
43
43
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
8.9
21.8
46
52
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
21.7
1328
10392
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
21.7
1801
14906
B07.84
ICD-10 Finland
Other specified disease caused by viral warts in the mouth
80.6
21.7
24
*
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
21.7
782
5484
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
21.6
1133
8602
ZXA05
NOMESCO Finland
Left side
1.6
21.6
737
5099
P01BA02
ATC
hydroxychloroquine; oral
2.0
21.4
276
1413
Z99.2
ICD-10 Finland
Dependence on renal dialysis
26.5
21.3
29
11
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
21.0
389
2270
103
Kela drug reimbursment
Diabetes, insulin-treated
1.6
21.0
706
4860
A02BC02
ATC
pantoprazole; systemic
1.4
20.7
2007
17000
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.2
20.7
229
1100
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
20.6
115
378
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
20.6
1211
9388
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
20.5
308
1670
J01FA10
ATC
azithromycin; systemic
1.4
20.5
2109
18036
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.7
20.5
70
151
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.4
20.5
179
768
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.0
20.4
123
424
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
20.4
239
1177
Z2221
NOMESCO Finland
Medical doctor
1.5
20.4
931
6861
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
4.0
20.4
82
208
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
20.3
420
2536
H3603, E103
ICD-10 Finland
NA
5.0
20.3
66
135
L17
ICPC
Foot/toe symptom/complaint
1.5
20.2
804
5748
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
9.4
20.0
41
44
ZXA10
NOMESCO Finland
Bilateral
1.6
20.0
567
3742
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
19.9
992
7435
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
10.1
19.8
39
39
-
ICD-10 Finland
NA
3.4
19.8
97
290
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
3.5
19.8
93
269
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.3
19.7
188
844
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.2
19.7
104
329
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
19.7
419
2552
602
Kela drug reimbursment
Children's severe malnutrition
8.1
19.7
44
55
D01AE16
ATC
amorolfine; topical
1.8
19.6
341
1945
JJC00
NOMESCO Finland
Allogenic transplantation of liver
16.4
19.6
31
19
RJ511
NOMESCO Finland
NA
16.4
19.6
31
19
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
19.6
431
2652
Q61.2
ICD-10 Finland
Polycystic kidney, autosomal dominant
9.8
19.6
39
40
R01AD09
ATC
mometasone; nasal
1.4
19.5
1542
12567
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
3.0
19.4
114
389
L85.89
ICD-10 Finland
Other specified epidermal thickening
14.7
19.4
32
22
R4110
NOMESCO Finland
Physiotherapy
1.5
19.3
807
5830
M04AA01
ATC
allopurinol; systemic
1.9
19.2
301
1655
ZXE00
NOMESCO Finland
One hour or less
1.4
19.2
1309
10389
C10AA04
ATC
fluvastatin; oral
2.1
19.2
223
1094
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.8
19.1
377
2239
Z94.2
ICD-10 Finland
Lung transplant status
16.8
19.1
30
18
RD210
NOMESCO Finland
NA
3.2
19.1
101
320
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
19.0
226
1116
KA9AE
NOMESCO Finland
Ultrasound examination transplanted kidney
20.1
19.0
28
14
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
20.1
19.0
28
14
A12BA01
ATC
potassium chloride; oral
3.0
19.0
112
383
R06.0
ICD-10 Finland
Dyspnoea
1.5
18.8
707
4986
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
18.7
1634
13507
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
18.6
1848
15596
D11AH01
ATC
tacrolimus; topical
4.9
18.6
61
127
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
18.5
1878
15899
A02BA02
ATC
ranitidine; systemic
1.6
18.4
530
3503
L04AB04
ATC
adalimumab; parenteral
3.4
18.4
91
275
S29
ICPC
Skin symptom/complaint other
1.6
18.3
538
3575
XCK10
NOMESCO Finland
Photography of fundus of eye
1.9
18.3
292
1620
H3600, E103
ICD-10 Finland
NA
4.4
18.2
66
152
TFJ02
NOMESCO Finland
Muscle biopsy of heart
17.6
18.2
28
16
E000007
ATC
NA
2.1
18.0
218
1087
C02CA01
ATC
prazosin; oral
4.7
17.9
60
128
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
3.5
17.9
84
244
A06AC01
ATC
ispaghula (psylla seeds); oral
1.5
17.9
669
4704
SPAT1260
SPAT
Consultation of another employee
1.6
17.9
569
3856
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
17.7
421
2640
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
3.9
17.7
72
185
ZZA00
NOMESCO Finland
Split skin graft
3.1
17.7
101
337
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.3
17.6
171
774
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.0
17.6
233
1208
B07.85
ICD-10 Finland
Unspecified viral wart of mouth
180.8
17.5
18
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.4
17.4
847
6291
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
3.7
17.4
75
203
N03AX16
ATC
pregabalin; oral
1.5
17.2
676
4802
A01AB09
ATC
miconazole; local oral
1.9
17.2
256
1387
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
17.2
234
1226
K00.40
ICD-10 Finland
Postnatal enamel hypoplasia
5.1
17.1
54
108
K02.1
ICD-10 Finland
Caries of dentine
1.3
17.1
2051
17735
C02AC05
ATC
moxonidine; oral
2.5
17.0
132
533
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.4
16.9
1216
9686
RJ410
NOMESCO Finland
NA
9.0
16.9
35
39
A46
ICD-10 Finland
Erysipelas
1.7
16.8
364
2224
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.1
16.8
65
160
R03BA01
ATC
beclometasone; inhalant
1.6
16.8
418
2655
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
5.2
16.8
52
102
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
4.2
16.7
64
156
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.3
16.7
159
711
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
4.4
16.7
60
138
UKC02
NOMESCO Finland
Cystoscopy
1.7
16.6
404
2549
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.2
16.6
87
275
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.0
16.6
219
1132
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
16.6
148
645
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.7
16.5
338
2034
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
16.5
187
907
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
6.0
16.4
45
76
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
18.0
16.4
25
14
RS220
NOMESCO Finland
NA
3.9
16.4
67
174
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
16.2
2535
22730
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
2.0
16.2
206
1050
R60.0
ICD-10 Finland
Localized oedema
1.8
16.1
291
1683
SPAT1263
SPAT
Sampling
1.3
16.1
1423
11697
L21.8
ICD-10 Finland
Other seborrhoeic dermatitis
4.2
16.1
61
148
A02BC05
ATC
esomeprazole; systemic
1.4
16.0
1209
9687
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.9
16.0
36
46
58200
ICD-8 Finland
Chronic nephritis, Cum uraemia
47.7
16.0
19
*
K06.10
ICD-10 Finland
Gingival fibromatosis
24.6
16.0
22
9
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
13.6
16.0
27
20
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.3
15.9
143
624
WX002
NOMESCO Finland
Sedation and analgesia
1.5
15.9
565
3919
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.9
15.8
233
1253
B01AB05
ATC
enoxaparin; parenteral
1.4
15.8
821
6157
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
2.1
15.8
171
815
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
11.2
15.7
29
26
N03.9
ICD-10 Finland
Chronic nephritic syndrome, unspecified
9.2
15.6
32
35
XF602
NOMESCO Finland
Bloodpressure monitoring
4.7
15.6
53
115
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.6
15.6
71
202
A10AA03
ATC
NA
5.1
15.6
49
98
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.9
15.6
95
332
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.6
15.6
424
2755
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
15.5
157
726
PC6DE
NOMESCO Finland
NA
160.6
15.5
16
*
Z01.2
ICD-10 Finland
Dental examination
1.3
15.4
1435
11863
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.1
15.4
168
802
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.9
15.4
218
1157
R03BB04
ATC
tiotropium bromide; inhalant
1.9
15.4
241
1325
BE00A
NOMESCO Finland
NA
38.2
15.4
19
5
TGC00
NOMESCO Finland
Bronchial lavation
3.0
15.3
88
297
A05AA02
ATC
ursodeoxycholic acid; oral
3.3
15.3
76
232
L30.3
ICD-10 Finland
Infective dermatitis
2.5
15.3
118
477
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
15.2
1190
9573
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
15.1
1098
8724
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
15.1
291
1714
B35.1
ICD-10 Finland
Tinea unguium
2.0
15.1
184
922
K65.0
ICD-10 Finland
Acute peritonitis
4.9
15.1
49
102
5850B
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA CUM URAEMIA]
45.2
15.1
18
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
15.0
1975
17157
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.7
15.0
304
1821
RJ190
NOMESCO Finland
NA
14.0
15.0
25
18
A10AE06
ATC
insulin degludec; parenteral
2.5
15.0
117
477
D04.7
ICD-10 Finland
Carcinoma in situ: Skin of lower limb, including hip
10.8
15.0
28
26
ZX108
NOMESCO Finland
Inhalation
5.3
14.9
45
86
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.9
14.9
206
1087
ZY010
NOMESCO Finland
Hospital outpatient
2.0
14.9
199
1033
WX110
NOMESCO Finland
Local anesthesy
1.3
14.8
2439
21865
K03.66
ICD-10 Finland
Tooth plaque
1.9
14.7
226
1235
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.1
14.7
175
869
G47.3
ICD-10 Finland
Sleep apnoea
1.5
14.7
597
4259
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.9
14.7
218
1179
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
25.1
14.7
20
8
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
2.9
14.7
90
317
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
14.6
815
6179
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.7
14.6
307
1860
QDE50
NOMESCO Finland
Dermabrasion of superficial lesion of skin of lower limb
+∞
14.6
14
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.6
14.6
106
413
R03BA02
ATC
budesonide; inhalant
1.5
14.6
544
3810
M05BB03
ATC
alendronic acid and colecalciferol; oral
3.4
14.6
71
214
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
14.5
217
1177
N03AX12
ATC
gabapentin; oral
1.6
14.5
432
2870
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
14.5
94
344
R06AE07
ATC
cetirizine; oral
1.3
14.4
1474
12318
C09AA02
ATC
enalapril; systemic
1.5
14.4
472
3205
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.0
14.4
194
1013
L73.8
ICD-10 Finland
Other specified follicular disorders
4.5
14.4
50
112
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
14.4
141
644
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.3
14.3
72
222
K50.8
ICD-10 Finland
Other Crohn disease
3.4
14.3
69
206
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.2
14.3
143
658
SPAT1310
SPAT
Counselling related to known health issue
1.4
14.3
1050
8339
J02AC02
ATC
itraconazole; systemic
1.5
14.3
528
3688
M25.5
ICD-10 Finland
Pain in joint
1.4
14.3
891
6886
XQ800
NOMESCO Finland
Prick test
1.7
14.3
275
1622
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.7
14.2
94
348
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
14.2
1325
10918
RJ425
NOMESCO Finland
NA
19.2
14.2
21
11
JJ5AT
NOMESCO Finland
NA
22.3
14.2
20
9
ZXC07
NOMESCO Finland
Carbon dioxide laser
22.3
14.2
20
9
M08.0
ICD-10 Finland
Juvenile rheumatoid arthritis
6.1
14.2
38
63
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
13.4
14.2
24
18
P01AB01
ATC
metronidazole; oral, rectal
1.3
14.2
1203
9772
RJ421
NOMESCO Finland
NA
9.7
14.2
28
29
K50.1
ICD-10 Finland
Crohn disease of large intestine
4.0
14.1
56
142
AA1AD
NOMESCO Finland
CT of head and brain
1.5
14.1
615
4447
ZXC15
NOMESCO Finland
Use of photodynamic technique
5.0
14.1
44
88
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
14.1
1640
13953
C07AB07
ATC
bisoprolol; oral
1.3
14.0
1186
9624
WZC30
NOMESCO Finland
Teaching
1.6
14.0
376
2434
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
14.0
1230
10039
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.3
14.0
130
577
RJ420
NOMESCO Finland
NA
8.4
14.0
30
36
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
13.9
832
6378
KMAK
NOMESCO Finland
NA
1.3
13.9
1785
15381
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
13.9
412
2734
V03AG01
ATC
sodium cellulose phosphate; systemic
12.7
13.9
24
19
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
17.6
13.8
21
12
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
53.5
13.8
16
*
5602
FHL
Internal fistula (eg Cimino)
53.5
13.8
16
*
2503B
ICD-9 Finland
Diabetes mellitus, Diabetes with other coma[SOKERITAUDIN AIHEUTTAMA MUNUAISSAIRAUS,TYYPPI I]
23.8
13.8
19
8
J01AA07
ATC
tetracycline; systemic
1.5
13.8
501
3489
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.7
13.8
94
355
AN1
HP
Coronary angiography
1.8
13.7
260
1526
D07AA02
ATC
hydrocortisone; topical
1.5
13.7
474
3261
RS221
NOMESCO Finland
NA
3.3
13.7
67
203
J31.0
ICD-10 Finland
Chronic rhinitis
1.8
13.7
247
1428
NF1AA
NOMESCO Finland
Hip X-ray examination
1.9
13.6
209
1143
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
14.7
13.6
22
15
58209
ICD-8 Finland
Chronic nephritis, Unspecified
14.7
13.6
22
15
B07.82
ICD-10 Finland
Local epithelial hypertrphy of mouth
+∞
13.5
13
*
S97
ICPC
Chronic ulcer skin
2.2
13.5
138
642
R42
ICD-10 Finland
Dizziness and giddiness
1.5
13.5
577
4153
L72.1
ICD-10 Finland
Trichilemmal cyst
1.9
13.5
191
1016
V03AE03
ATC
lanthanum carbonate; oral
9.4
13.4
27
29
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
4.9
13.4
43
89
XQ802
NOMESCO Finland
Epicutan test
2.1
13.3
143
681
R03DC03
ATC
montelukast; oral
1.5
13.2
499
3498
H05BX01
ATC
cinacalcet; oral
6.6
13.2
33
50
L85.3
ICD-10 Finland
Xerosis cutis
4.7
13.2
44
95
B01AA03
ATC
warfarin; systemic
1.5
13.2
417
2810
7531A
ICD-9 Finland
Congenital anomalies of urinary system, Cystic kidney disease
40.2
13.1
16
*
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.8
13.1
83
300
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.6
13.1
92
354
C08CA13
ATC
lercanidipine; oral
1.7
13.0
303
1889
C10AA03
ATC
pravastatin; oral
2.0
13.0
174
906
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
28.4
12.9
17
6
4AA09
NOMESCO Finland
NA
28.4
12.9
17
6
J01FA09
ATC
clarithromycin; systemic
1.3
12.9
1006
8044
Q61.0
ICD-10 Finland
Congenital single renal cyst
22.6
12.9
18
8
D04.8
ICD-10 Finland
Carcinoma in situ: Skin of other sites
50.2
12.8
15
*
KAS40
NOMESCO Finland
Excision of transplanted kidney
50.2
12.8
15
*
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.4
12.8
758
5793
WX720
NOMESCO Finland
Own respiration
2.3
12.8
120
537
L04AB01
ATC
etanercept; parenteral
3.2
12.8
67
214
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.6
12.8
343
2223
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
12.7
332
2134
WW400
NOMESCO Finland
Plasmaferesis
14.1
12.7
21
15
C44.52
ICD-10 Finland
Spinocellular carcinoma of the skin on the torso
10.5
12.7
24
23
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
12.7
303
1899
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
5.1
12.7
39
77
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.8
12.7
83
305
K07.60
ICD-10 Finland
Snapping jaw
1.9
12.7
176
928
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
12.7
269
1635
D05BB02
ATC
acitretin; oral
2.9
12.7
78
276
S21
ICPC
Skin texture symptom/complaint
1.6
12.6
370
2451
A02BA01
ATC
cimetidine; systemic
15.5
12.6
20
13
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
12.6
541
3893
FQA00
NOMESCO Finland
Orthotopic transplantation of heart
32.1
12.6
16
5
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.7
12.6
256
1538
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
12.5
394
2648
B01.9
ICD-10 Finland
Varicella without complication
11.0
12.5
23
21
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.5
12.5
446
3088
M08.3
ICD-10 Finland
Juvenile polyarthritis (seronegative)
5.0
12.4
39
79
D82
ICPC
Teeth/gum disease
1.3
12.4
1179
9696
D02AX
ATC
Other emollients and protectives
2.2
12.4
127
591
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
5.8
12.4
34
59
X58
ICD-10 Finland
Exposure to other specified factors
1.5
12.3
432
2976
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
12.3
560
4079
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
5.0
12.3
38
76
GDG10
NOMESCO Finland
Bilateral transplantation of lung
14.4
12.3
20
14
8070/3-C44.6
ICD-O-3
Squamous cell carcinoma, NOS, of skin of upper limb and shoulder
37.7
12.2
15
*
187
Kela drug reimbursment
MPA
37.7
12.2
15
*
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.1
12.2
135
650
Z00.0
ICD-10 Finland
General medical examination
1.4
12.2
565
4128
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.8
12.2
228
1334
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
12.1
679
5136
XW000
NOMESCO Finland
Bone marrow biopsy
2.3
12.1
112
498
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
12.1
783
6070
ZXC12
NOMESCO Finland
Pulse colorlaser
6.9
12.1
29
42
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.8
12.1
75
268
5828A
ICD-9 Finland
Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]
26.8
12.0
16
6
PB1BC
NOMESCO Finland
Extensive angiography of upper extremity with X-ray
21.3
12.0
17
8
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
8.7
12.0
25
29
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.7
11.9
233
1381
N11.8
ICD-10 Finland
Other chronic tubulo-interstitial nephritis
13.4
11.9
20
15
R51.80
ICD-10 Finland
Headache
1.5
11.9
492
3511
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
11.9
271
1677
D11AX14
ATC
[U] tacrolimus; topical
5.7
11.9
33
58
R01AD12
ATC
fluticasone furoate; nasal
1.3
11.9
984
7920
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
2.9
11.9
70
243
L04AA10
ATC
sirolimus; oral
46.8
11.9
14
*
R05
ICD-10 Finland
Cough
1.4
11.9
562
4119
M79.1
ICD-10 Finland
Myalgia
1.5
11.8
395
2693
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
11.8
373
2508
H02AB07
ATC
prednisone; oral
1.5
11.8
381
2579
N08.5*M31.3
ICD-10 Finland
Glomerular disorders in Wegener's granulomatosis
14.7
11.8
19
13
6BA02
NOMESCO Finland
NA
8.4
11.8
25
30
R03AC03
ATC
terbutaline; inhalant
1.5
11.7
425
2952
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
8.9
11.7
24
27
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
2.6
11.7
85
333
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.7
11.7
227
1344
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.6
11.7
291
1848
PG1XE
NOMESCO Finland
Other ultrasound examination of blood vessel not elsewhere classified
6.3
11.7
30
48
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
16.4
11.6
18
11
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
2.9
11.6
69
241
QXA40
NOMESCO Finland
Skin laser treatment or photocoagulation, unspecified location
65.1
11.6
13
*
6119
FHL
Other measure in this category
65.1
11.6
13
*
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
3.4
11.6
54
159
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
11.6
301
1933
N03.3
ICD-10 Finland
Chronic nephritic syndrome, diffuse mesangial proliferative glomerulonephritis
22.9
11.6
16
7
L01AA01
ATC
cyclophosphamide; systemic
8.1
11.5
25
31
B08.1
ICD-10 Finland
Molluscum contagiosum
9.2
11.5
23
25
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
11.5
571
4225
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
11.4
630
4747
75310
ICD-8 Finland
Congenital anomalies of urinary system, Ren polycysticus bilateralis
120.4
11.4
12
*
C09CA01
ATC
losartan; oral
1.4
11.4
574
4256
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.9
11.4
36
74
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.6
11.4
81
316
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
11.4
274
1726
A07EC01
ATC
sulfasalazine; oral, rectal
1.7
11.4
243
1481
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
11.4
151
784
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
11.3
832
6569
N03.8
ICD-10 Finland
Chronic nephritic syndrome, other
11.8
11.3
20
17
QDE15
NOMESCO Finland
Excision of other superficial lesion of skin in lower limb
15.1
11.3
18
12
ZXD20
NOMESCO Finland
Day surgery
1.5
11.3
394
2713
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
11.3
391
2688
E000003
ATC
NA
1.9
11.3
151
790
WX882
NOMESCO Finland
High dependency care
2.3
11.2
98
424
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
3.6
11.2
49
137
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
9.6
11.2
22
23
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
11.2
264
1652
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.2
11.2
111
511
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.5
11.2
85
342
A10AD04
ATC
insulin lispro; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
5.7
11.1
31
55
C07AG02
ATC
carvedilol; oral
1.9
11.1
150
786
N04.80
ICD-10 Finland
Congenital nephrotic syndrome of the Finnish type
25.1
11.1
15
6
A07EA06
ATC
budesonide; oral, local oral
2.2
11.1
111
513
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
11.1
199
1147
QAE15
NOMESCO Finland
Excision of other superficial lesion of skin from head and neck
12.7
11.1
19
15
T86.1
ICD-10 Finland
Kidney transplant failure and rejection
20.1
11.1
16
8
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
11.1
119
569
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
11.1
204
1186
A01AB04
ATC
amphotericin B; local oral
2.1
11.1
121
583
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.7
11.1
213
1258
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
4.2
11.0
40
95
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
11.0
1227
10276
C44.81
ICD-10 Finland
Overall basocellular carcinoma of the skin
8.6
11.0
23
27
TQW02
NOMESCO Finland
Removal of wart
10.0
11.0
21
21
WX320
NOMESCO Finland
Spinalanesthesy
1.4
11.0
613
4623
ZX199
NOMESCO Finland
Other rote
9.2
11.0
22
24
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
11.0
96
415
B34.9
ICD-10 Finland
Viral infection, unspecified
2.2
11.0
113
531
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
2.6
11.0
77
297
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
10.9
377
2587
5829A
ICD-9 Finland
Chronic glomerulonephritis with unspecified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA NUD ,EI NEFR SDR]
43.4
10.9
13
*
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
10.9
553
4103
J01EA01
ATC
trimethoprim; systemic
1.4
10.9
719
5579
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
5.1
10.9
33
65
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
10.9
202
1180
H26.2
ICD-10 Finland
Complicated cataract
3.6
10.8
47
131
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
10.8
515
3773
A04AA01
ATC
ondansetron; systemic, rectal
1.8
10.8
178
998
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
15.5
10.8
17
11
D22.6
ICD-10 Finland
Melanocytic naevi of upper limb, including shoulder
3.3
10.8
53
163
L30.8
ICD-10 Finland
Other specified dermatitis
2.7
10.8
73
277
QXA20
NOMESCO Finland
Skin abrasion, unspecified location
8.3
10.8
23
28
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
8.3
10.8
23
28
SBB10
NOMESCO Finland
Teeth copy
1.6
10.8
253
1581
-1
NOMESCO Finland
NA
1.3
10.7
1175
9806
3AC01
NOMESCO Finland
NA
3.8
10.7
44
117
4059B
ICD-9 Finland
Secondary hypertension, Unspecified[HYPERTONIA SECUNDARIA ALIA DEFINITA]
28.1
10.7
14
5
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
10.7
146
767
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
4.3
10.6
38
89
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
10.6
343
2321
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
10.6
460
3314
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
10.6
117
567
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
3.0
10.6
59
199
C08CA03
ATC
isradipine; systemic
3.9
10.5
42
109
ZX121
NOMESCO Finland
Central venous catheter
7.0
10.5
25
36
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.8
10.5
67
245
C10AA05
ATC
atorvastatin; oral
1.3
10.5
882
7094
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
10.5
946
7690
A07EC02
ATC
mesalazine; oral, rectal
1.8
10.5
177
1003
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
10.5
1403
12007
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.5
148
788
K50.9
ICD-10 Finland
Crohn disease, unspecified
3.0
10.4
60
205
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
10.4
417
2956
A06AD11
ATC
lactulose; oral
1.5
10.4
326
2189
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.7
10.4
203
1203
R01AD08
ATC
fluticasone; nasal
1.3
10.4
878
7069
R11
ICD-10 Finland
Nausea and vomiting
1.7
10.4
238
1476
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.8
10.4
187
1081
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
10.3
260
1653
R01AD01
ATC
beclometasone; nasal
1.4
10.3
443
3181
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
10.3
204
1213
TJW99
NOMESCO Finland
Other minor procedure in gastrointestinal endoscopy
8.2
10.3
22
27
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.3
10.3
739
5805
XKD00
NOMESCO Finland
Uroflowmetry
1.5
10.3
348
2381
A03FA02
ATC
cisapride; oral, rectal
1.7
10.3
193
1130
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
2.2
10.3
105
492
ZQX00
NOMESCO Finland
0-4% of the skin
10.6
10.3
19
18
C44.22
ICD-10 Finland
Spinocellular carcinoma of the skin of the outer ear and the outer ear canal
10.6
10.3
19
18
D11AH02
ATC
pimecrolimus; topical
6.0
10.3
27
45
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
10.3
1314
11175
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.1
10.2
117
575
H13
ICPC
Plugged feeling ear
1.4
10.2
457
3309
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
10.2
166
929
B01AC04
ATC
clopidogrel; oral
1.5
10.2
315
2108
H3601, E103
ICD-10 Finland
NA
3.4
10.0
47
140
R03AC12
ATC
salmeterol; inhalant
2.0
10.0
120
602
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.0
10.0
122
616
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
10.0
10.0
19
19
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.7
10.0
67
252
C02DE02
ATC
NA
4.4
10.0
35
81
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
9.9
698
5463
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
4.7
9.9
32
68
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
9.9
204
1232
S01AD03
ATC
aciclovir; ophthalmic
2.4
9.9
81
343
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.1
9.9
107
515
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
12.2
9.8
17
14
WW500
NOMESCO Finland
Blood transfusion
2.1
9.8
107
516
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.4
9.8
408
2911
NG1AE
NOMESCO Finland
Knee joint ultrasound exmination
3.4
9.8
45
132
CBB40
NOMESCO Finland
Electrocoagulation of lesion of eyelid
26.1
9.8
13
5
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
2.6
9.8
70
274
S04
ICPC
Lump/swelling localized
1.6
9.8
288
1907
5839X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With unspecified pathological lesion in kidney
20.1
9.8
14
7
ZYB02
NOMESCO Finland
Outreach service at unit of another specialty
5.7
9.8
27
48
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
9.8
187
1104
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
10.6
9.8
18
17
L04AA17
ATC
[U] adalimumab; parenteral
8.7
9.8
20
23
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
9.7
461
3375
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
9.5
9.7
19
20
WX204
NOMESCO Finland
Axillary plexus blockaced
2.2
9.7
94
430
ULA02
NOMESCO Finland
Kolposcopy
1.6
9.7
286
1894
212
Kela drug reimbursment
Gout
2.9
9.7
56
192
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.3
9.7
88
390
H01AC01
ATC
somatropin; parenteral
4.9
9.7
30
61
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
1.5
9.7
325
2217
CJB10
NOMESCO Finland
Laser discission of secondary cataract
1.8
9.7
163
924
ACC51
NOMESCO Finland
Release of median nerve
1.7
9.7
193
1152
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
9.7
203
1231
B35.3
ICD-10 Finland
Tinea pedis
2.0
9.7
115
576
L93.0
ICD-10 Finland
Discoid lupus erythematosus
6.1
9.7
25
41
L04AA13
ATC
leflunomide; oral
2.5
9.6
74
303
H03.1*B00.5
ICD-10 Finland
Herpesviral dermatitis of eyelid
55.1
9.6
11
*
BBA50
NOMESCO Finland
Total parathyroidectomy
55.1
9.6
11
*
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
3.1
9.6
50
161
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.4
9.6
82
353
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
9.6
1018
8438
CKC12
NOMESCO Finland
Photocoagulation of retina
2.0
9.6
121
620
M01AC06
ATC
meloxicam; systemic, rectal
1.3
9.6
983
8113
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
9.5
297
1993
D06BX01
ATC
metronidazole; topical
1.5
9.5
285
1893
M10.3
ICD-10 Finland
Gout due to impairment of renal function
9.1
9.5
19
21
SPAT1210
SPAT
Application of cast or individual aid
1.9
9.5
131
695
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
5.7
9.5
26
46
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
9.5
612
4723
J45.8
ICD-10 Finland
Mixed asthma
2.2
9.5
92
422
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
9.5
449
3284
NHG80
NOMESCO Finland
Fusion of first tarsometatarsal joint
2.2
9.5
97
456
SPAT1255
SPAT
Intravenous administration of medicine
1.8
9.5
170
984
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.6
9.4
23
35
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
7.5
9.4
21
28
395
Kela drug reimbursment
Dupilumab
17.6
9.4
14
8
RJ426
NOMESCO Finland
NA
+∞
9.4
9
*
5820A
ICD-9 Finland
Chronic glomerulonephritis, With lesion of proliferative glomerulonephritis[GLOMERULONEPHRITIS CHRONICA PROLIF,EI NEFR SDR]
+∞
9.4
9
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
9.4
380
2699
63
HP
Cardiac muscle biopsy
21.7
9.3
13
6
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.8
9.3
57
205
TBW99
NOMESCO Finland
Other minor procedure in endocrine surgery
4.2
9.3
34
82
C02EA02
ATC
NA
2.2
9.3
89
406
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
5.6
9.3
26
47
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
9.3
850
6898
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.5
9.3
42
122
XX4BW
NOMESCO Finland
NA
6.9
9.3
22
32
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.6
9.3
224
1412
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.7
9.3
208
1287
ZYC01
NOMESCO Finland
Remote contact by phone
1.8
9.3
143
789
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.1
9.3
48
155
Z01.9
ICD-10 Finland
Special examination, unspecified
1.8
9.3
144
794
RJ414
NOMESCO Finland
NA
9.5
9.3
18
19
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.5
9.2
351
2462
L04AA11
ATC
[U] etanercept; parenteral
6.4
9.2
23
36
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.3
9.2
1012
8420
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
9.2
243
1568
40399
ICD-8 Finland
Hypertensive renal disease
13.7
9.2
15
11
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
3.5
9.1
41
119
D22.7
ICD-10 Finland
Melanocytic naevi of lower limb, including hip
2.5
9.1
69
279
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
9.1
626
4875
PG1AE
NOMESCO Finland
Ultrasound examination of artery not elsewher classified
7.7
9.1
20
26
GD1AD
NOMESCO Finland
Thorax CT examination
2.0
9.1
108
539
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
4.9
9.1
28
57
R06AX27
ATC
desloratadine; oral
1.3
9.1
882
7219
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.6
9.1
65
254
N08.2
ICD-10 Finland
Glomerular disorders in blood diseases and disorders involving the immune mechanism
8.3
9.0
19
23
EB1WA
NOMESCO Finland
NA
4.2
9.0
33
80
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
9.0
260
1714
TJA30
NOMESCO Finland
Peritoneal dialysis
36.8
9.0
11
*
S20
ICPC
Corn/callosity
2.8
9.0
57
208
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.7
9.0
29
62
NHQ40
NOMESCO Finland
Amputation of toe
3.3
9.0
43
131
D07BC01
ATC
betamethasone and antiseptics; topical
1.5
9.0
328
2279
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
9.0
458
3394
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.8
9.0
151
856
SPAT1312
SPAT
General health counselling
1.3
9.0
1083
9109
M54.5
ICD-10 Finland
Low back pain
1.3
8.9
995
8284
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
7.4
8.9
20
27
WX202
NOMESCO Finland
Supraclavicular plexus blockade
3.1
8.9
47
154
R52.9
ICD-10 Finland
Pain, unspecified
1.6
8.9
228
1461
7101
FHL
Needle biopsy in the operating room
24.1
8.9
12
5
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.2
8.9
83
375
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
8.9
643
5046
L03
ICPC
Low back symptom/complaint
1.3
8.9
712
5673
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
12.5
8.9
15
12
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.6
8.8
256
1690
L08
ICPC
Shoulder symptom/complaint
1.4
8.8
497
3747
H01.0
ICD-10 Finland
Blepharitis
1.7
8.8
166
977
J01CF02
ATC
cloxacillin; systemic
2.4
8.8
71
299
XPX08
NOMESCO Finland
Intraoperative flow measurement
4.9
8.8
27
55
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
8.8
405
2949
D04.2
ICD-10 Finland
Carcinoma in situ: Skin of ear and external auricular canal
10.7
8.8
16
15
KAS20
NOMESCO Finland
Allogenic transplantation of kidney from living donor
10.7
8.8
16
15
N19
ICD-10 Finland
Unspecified kidney failure
2.4
8.8
68
281
R03BA05
ATC
fluticasone; inhalant
1.4
8.8
552
4239
1XC02
NOMESCO Finland
NA
4.6
8.8
29
64
25002
ICD-8 Finland
Diabetes mellitus, Retinopathia diabetica
9.5
8.8
17
18
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
4.1
8.7
32
78
L70.0
ICD-10 Finland
Acne vulgaris
1.9
8.7
116
606
S10
ICPC
Boil/carbuncle
1.8
8.7
156
902
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
8.7
333
2337
Z94.5
ICD-10 Finland
Skin transplant status
50.1
8.7
10
*
U14
ICPC
Kidney symptom/complaint
3.2
8.7
43
135
L28
ICPC
Limited function/disability (L)
1.5
8.7
345
2444
D05AX52
ATC
calcipotriol, combinations; topical
1.8
8.7
152
875
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.5
8.6
38
109
SCC01
NOMESCO Finland
Simple fluorination of mouth or other corresponding procedure
2.0
8.6
111
574
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
8.6
105
533
K03.00
ICD-10 Finland
Approximal wear
1.8
8.6
155
898
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.6
8.6
59
227
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
6.1
8.6
22
36
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
3.2
8.6
43
136
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
8.6
978
8160
R06AX13
ATC
loratadine; oral
1.4
8.5
475
3576
R05
ICPC
Cough
1.3
8.5
681
5422
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
3.5
8.5
37
105
C44.72
ICD-10 Finland
Spinocellular carcinoma of the skin of the lower extremity including the hip
10.0
8.5
16
16
58399
ICD-8 Finland
Nephritis, unqualified
10.0
8.5
16
16
QDA10
NOMESCO Finland
Incision of skin of lower limb
3.8
8.5
34
90
L88
ICPC
Rheumatoid/seropositive arthritis
2.0
8.5
106
542
M05BX04
ATC
denosumab; parenteral
1.9
8.5
112
583
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
2.1
8.5
97
479
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
27.6
8.5
11
*
C10AA01
ATC
simvastatin; oral
1.3
8.5
954
7945
D11AH05
ATC
dupilumab; topical
20.1
8.5
12
6
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
8.4
349
2487
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.0
8.4
103
520
Z96.4
ICD-10 Finland
Presence of endocrine implants
7.3
8.4
19
26
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.1
8.4
90
433
ECA30
NOMESCO Finland
Excision of lesion of gingiva
3.5
8.4
37
106
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
3.5
8.4
37
106
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
5.6
8.4
23
41
UJF92
NOMESCO Finland
Capsular endoscopy
2.4
8.4
66
275
Z94.3
ICD-10 Finland
Heart and lungs transplant status
90.3
8.4
9
*
TKA05
NOMESCO Finland
Aspiration cytology of kidney
90.3
8.4
9
*
Q64.2
ICD-10 Finland
Congenital posterior urethral valves
90.3
8.4
9
*
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
90.3
8.4
9
*
R03BC03
ATC
nedocromil; inhalant
1.6
8.4
191
1187
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
3.6
8.4
36
101
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.9
8.4
49
171
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
8.4
329
2320
R35
ICD-10 Finland
Polyuria
1.8
8.4
148
854
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.8
8.4
144
822
M77.4
ICD-10 Finland
Metatarsalgia
1.7
8.4
155
908
K50.0
ICD-10 Finland
Crohn disease of small intestine
2.7
8.4
55
208
DHB00
NOMESCO Finland
Excision of lesion of external nose
4.1
8.3
31
77
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
2.3
8.3
74
328
177
Kela drug reimbursment
Insulin glargine 300 U / ml
2.4
8.3
65
270
R06AX22
ATC
ebastine; oral
1.4
8.3
498
3794
WX892
NOMESCO Finland
Monitored bed care
1.6
8.3
193
1209
R05FB02
ATC
cough suppressants and expectorants
1.3
8.3
1001
8406
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.4
8.3
333
2363
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
8.2
199
1257
R03AK08
ATC
formoterol and beclometasone; inhalant
2.0
8.2
106
548
QXE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in uspecified region
4.4
8.2
28
64
N06AX11
ATC
mirtazapine; oral
1.3
8.2
901
7478
A12AA06
ATC
calcium lactate gluconate; oral
14.5
8.2
13
9
J01FA01
ATC
erythromycin; systemic
1.4
8.2
448
3363
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
2.2
8.2
83
390
N02AA05
ATC
oxycodone; systemic
1.5
8.2
308
2159
J01MA06
ATC
norfloxacin; oral
1.4
8.2
341
2435
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.4
8.1
364
2634
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
6.0
8.1
21
35
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
6.0
8.1
21
35
R03AK07
ATC
formoterol and budesonide; inhalant
1.3
8.1
547
4243
R03AC13
ATC
formoterol; inhalant
1.8
8.1
125
689
H26.4
ICD-10 Finland
After-cataract
1.7
8.1
173
1056
ZX112
NOMESCO Finland
Subcutaneous
2.5
8.1
60
242
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.4
8.1
67
287
L91.0
ICD-10 Finland
Hypertrophic scar
2.6
8.1
56
217
SPAT1285
SPAT
Provision of consultation response
1.7
8.1
149
872
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.6
8.1
184
1143
L57.9
ICD-10 Finland
Skin changes due to chronic exposure to nonionizing radiation, unspecified
11.7
8.1
14
12
Z45.1
ICD-10 Finland
Adjustment and management of infusion pump
11.7
8.1
14
12
L71.8
ICD-10 Finland
Other rosacea
3.0
8.1
43
143
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
8.1
281
1935
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.3
8.0
688
5523
D64.9
ICD-10 Finland
Anaemia, unspecified
1.6
8.0
206
1320
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.0
8.0
96
484
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
10.0
8.0
15
15
Q61.1
ICD-10 Finland
Polycystic kidney, autosomal recessive
22.1
8.0
11
5
NH1CG
NOMESCO Finland
Ankle and foot extensive MRI examination with high intensity magnet
2.6
8.0
53
202
ZZR00
NOMESCO Finland
Flap of skin
2.5
8.0
60
245
XCH00
NOMESCO Finland
Eye pressure measurement
2.0
8.0
96
486
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
5.3
8.0
23
44
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.7
8.0
51
189
377
Kela drug reimbursment
Apremilast and dimethyl fumarate (psoriasis)
7.2
7.9
18
25
N05CF01
ATC
zopiclone; oral
1.3
7.9
831
6855
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
2.8
7.9
48
174
C03DA01
ATC
spironolactone; oral
1.5
7.9
232
1538
321
Kela drug reimbursment
Paricalcitol and cinacalcet
4.9
7.9
24
49
UDC00
NOMESCO Finland
Ear microscopy
1.6
7.9
198
1265
Z2445
NOMESCO Finland
Psychologist
1.7
7.8
143
834
M81.4
ICD-10 Finland
Drug-induced osteoporosis
6.1
7.8
20
33
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
7.8
213
1385
ND2BA
NOMESCO Finland
Hand and fingers extensive X-ray examination
2.3
7.8
70
311
D23.5
ICD-10 Finland
Benign neoplasm: Skin of trunk
2.3
7.8
67
291
D89.80
ICD-10 Finland
Immunoglobulin A (IgA) deposits in organisms
8.5
7.8
16
19
120
Kela drug reimbursment
Hypogammaglobulinaemia
9.4
7.8
15
16
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
4.1
7.8
28
68
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.4
7.8
356
2588
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
7.7
247
1671
SCD02
NOMESCO Finland
Removal of tooth plaque or tartar
3.6
7.7
33
93
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.9
7.7
108
577
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.6
7.7
182
1141
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
7.7
1791
16104
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
1.9
7.7
108
578
E87.5
ICD-10 Finland
Hyperkalaemia
3.1
7.7
40
131
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.7
7.7
154
926
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
4.2
7.7
27
64
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
4.2
7.7
27
64
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
7.7
800
6588
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
7.7
275
1905
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
2.3
7.7
66
287
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.3
7.7
64
276
L29.9
ICD-10 Finland
Pruritus, unspecified
2.3
7.7
69
308
D23.7
ICD-10 Finland
Benign neoplasm: Skin of lower limb, including hip
3.1
7.7
39
126
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
2.5
7.7
55
220
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.0
7.6
91
459
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
3.9
7.6
29
74
SPAT1229
SPAT
Assessment of need for aid
1.6
7.6
178
1114
L03AA02
ATC
filgrastim; parenteral
2.3
7.6
67
297
M48.0
ICD-10 Finland
Spinal stenosis
1.5
7.6
244
1652
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
7.6
170
1054
QXA99
NOMESCO Finland
Other skin division, biopsy or local destruction, unspecified location
18.4
7.6
11
6
C10AX09
ATC
ezetimibe; oral
1.5
7.6
245
1660
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.6
7.6
206
1343
PBM09
NOMESCO Finland
Closure of arteriovenous fistula of brachial artery
25.0
7.6
10
*
L16
ICPC
Ankle symptom/complaint
1.5
7.6
296
2088
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.4
7.5
406
3035
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.9
7.5
111
606
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
3.9
7.5
29
75
L50.3
ICD-10 Finland
Dermatographic urticaria
2.6
7.5
53
209
M54.2
ICD-10 Finland
Cervicalgia
1.6
7.5
196
1264
A03
ICPC
Fever
1.3
7.5
537
4202
M35.1
ICD-10 Finland
Other overlap syndromes
5.7
7.5
20
35
M01CB01
ATC
sodium aurothiomalate; parenteral
2.9
7.5
43
148
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
2.6
7.5
50
192
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
2.8
7.5
44
156
L13
ICPC
Hip symptom/complaint
1.4
7.5
368
2710
A07AA09
ATC
vancomycin; oral
3.2
7.5
36
112
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
2.7
7.5
49
186
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
7.5
770
6332
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
2.5
7.4
56
229
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
7.4
173
1083
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
7.4
462
3538
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.3
7.4
67
298
3A006
NOMESCO Finland
NA
80.2
7.4
8
*
C44.82
ICD-10 Finland
Overall spinocellular carcinoma of the skin
80.2
7.4
8
*
KAS96
NOMESCO Finland
Other transplantation of kidney or related procedure
80.2
7.4
8
*
7155
FHL
Exploration of the graft
80.2
7.4
8
*
7158
FHL
Graft removal
80.2
7.4
8
*
SBA00
NOMESCO Finland
Microbiological examinations
2.2
7.4
68
308
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.3
7.4
65
288
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
7.4
196
1267
WX402
NOMESCO Finland
General anaesthesia
1.3
7.4
475
3657
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
13.4
7.4
12
9
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.7
7.4
149
899
E000004
ATC
NA
2.2
7.3
69
313
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.7
7.3
48
182
N06AB04
ATC
citalopram; systemic
1.3
7.3
579
4593
L21.0
ICD-10 Finland
Seborrhoea capitis
3.3
7.3
34
103
5850A
ICD-9 Finland
Chronic renal failure[INSUFFICIENTIA RENIS CHRONICA SINE URAEMIA]
+∞
7.3
7
*
L85.80
ICD-10 Finland
Hudhorn
6.8
7.3
17
25
ZXC20
NOMESCO Finland
Use of chemical agents
2.6
7.3
48
183
K30
ICD-10 Finland
Functional dyspepsia
1.5
7.3
277
1945
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
3.2
7.3
35
109
B00.10
ICD-10 Finland
Herpes simplex facialis
4.9
7.3
22
45
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
7.2
168
1053
F02
ICPC
Red eye
1.8
7.2
123
701
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
3.6
7.2
30
83
B37.09
ICD-10 Finland
Unspecified candidal stomatitis
3.6
7.2
30
83
K72.0
ICD-10 Finland
Acute and subacute hepatic failure
6.2
7.2
18
29
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
7.2
837
6975
N03.0
ICD-10 Finland
Chronic nephritic syndrome, minor glomerular abnormality
15.8
7.2
11
7
N083, E102
ICD-10 Finland
NA
15.8
7.2
11
7
ZX197
NOMESCO Finland
NA
15.8
7.2
11
7
A98
ICPC
Health maint/preventive medicine
1.5
7.2
3588
35002
G04CA02
ATC
tamsulosin; oral
1.4
7.2
428
3253
NF1DA
NOMESCO Finland
X-ray of hips
2.5
7.2
52
209
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
3.2
7.2
35
110
G44.2
ICD-10 Finland
Tension-type headache
1.4
7.2
377
2807
B04AB02
ATC
NA
2.9
7.2
41
141
5838X
ICD-9 Finland
Nephritis and nephropathy, not specified as acute or chronic, With other specified pathological lesion in kidney[NEPHRITIS INTERSTITIALIS CHRONICA ALIA DEFINITA]
30.1
7.1
9
*
I15.9
ICD-10 Finland
Secondary hypertension, unspecified
3.7
7.1
29
79
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
3.8
7.1
28
74
UJH02
NOMESCO Finland
Anoscopy
1.8
7.1
109
601
BC00A
NOMESCO Finland
NA
20.0
7.1
10
5
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.9
7.1
103
557
WZA90
NOMESCO Finland
Other doctors statement
1.3
7.1
725
5950
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.1
66
301
NH1AD
NOMESCO Finland
Ankle and foot CT
2.3
7.1
60
261
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
7.1
122
701
2507B
ICD-9 Finland
Diabetes mellitus, Diabetes with peripheral circulatory disorders[DIABETES MELLITUS CUM COMPLICAT ALIA ,TYYPPI I]
7.9
7.1
15
19
L20.8
ICD-10 Finland
Other atopic dermatitis
3.0
7.1
38
128
58199
ICD-8 Finland
Nephrotic syndrome
12.0
7.1
12
10
M31.3
ICD-10 Finland
Wegener granulomatosis
5.3
7.1
20
38
D11AX15
ATC
[U] pimecrolimus; topical
6.0
7.1
18
30
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
6.0
7.1
18
30
QDH00
NOMESCO Finland
Avulsion of toe nail
5.6
7.0
19
34
WX704
NOMESCO Finland
Intubation
1.6
7.0
191
1245
R09
ICPC
Sinus symptom/complaint
1.5
7.0
240
1646
TNG11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in knee
3.6
7.0
29
80
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.4
7.0
334
2444
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
7.0
92
480
H02.3
ICD-10 Finland
Blepharochalasis
1.7
7.0
134
797
J30.3
ICD-10 Finland
Other allergic rhinitis
1.8
7.0
112
629
M05BA07
ATC
risedronic acid; oral
2.1
7.0
72
342
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.0
7.0
81
403
N05BB01
ATC
hydroxyzine; systemic
1.6
7.0
173
1103
NH3FA
NOMESCO Finland
Weight-bearing X-ray of foot
2.4
7.0
56
238
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
3.1
6.9
35
113
F03
ICPC
Eye discharge
1.6
6.9
171
1088
A28
ICPC
Limited function/disability NOS
1.4
6.9
292
2089
A03CA02
ATC
clidinium and psycholeptics; oral
1.7
6.9
128
754
ZX100
NOMESCO Finland
Oral
2.9
6.9
40
140
L71.9
ICD-10 Finland
Rosacea, unspecified
2.2
6.9
64
291
KAC00
NOMESCO Finland
Nephrectomy
5.8
6.9
18
31
H36.01
ICD-10 Finland
Diabetic maculopathy
3.0
6.9
37
125
K65.9
ICD-10 Finland
Peritonitis, unspecified
7.5
6.9
15
20
L08.0
ICD-10 Finland
Pyoderma
3.2
6.9
33
103
NH3CG
NOMESCO Finland
Extensive MRI of foot
4.1
6.9
25
62
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
6.9
397
3006
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.7
6.9
125
731
VALMI
NOMESCO Finland
NA
1.2
6.8
834
6990
C10AA07
ATC
rosuvastatin; oral
1.3
6.8
544
4320
H00.1
ICD-10 Finland
Chalazion
1.9
6.8
97
523
DHB10
NOMESCO Finland
Excision of lesion of internal nose
4.8
6.8
21
44
D10AF01
ATC
clindamycin; topical
1.7
6.8
147
902
UJF02
NOMESCO Finland
Peroral enteroscopy
4.4
6.8
23
53
K83.0
ICD-10 Finland
Cholangitis
2.7
6.8
42
155
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.6
6.8
46
179
H05BX02
ATC
paricalcitol; systemic
10.9
6.8
12
11
NC1AA
NOMESCO Finland
Elbow X-ray examination without contrast
2.0
6.8
84
431
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
6.1
6.8
17
28
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
1.9
6.8
90
473
N08.5*M30.0
ICD-10 Finland
Glomerular disorders in polyarteritis nodosa
40.1
6.8
8
*
D05AX02
ATC
calcipotriol; topical
1.8
6.7
102
562
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.1
6.7
70
333
TK823
NOMESCO Finland
Peritoneal permeability analysis
16.7
6.7
10
6
TQW40
NOMESCO Finland
Remowal of suture of skin
1.6
6.7
177
1147
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.3
6.7
60
268
D86.0
ICD-10 Finland
Sarcoidosis of lung
2.8
6.7
40
144
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.4
6.7
30
89
Z71.8
ICD-10 Finland
Other specified counselling
1.3
6.7
725
5990
QCE15
NOMESCO Finland
Excision of other superficial lesion of skin in upper limb
22.5
6.7
9
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.7
6.7
125
737
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.6
6.7
160
1010
DAB00
NOMESCO Finland
Excision of lesion of auricle
3.6
6.7
28
79
K05.30
ICD-10 Finland
Periodontitis complex
1.4
6.7
310
2263
TK810
NOMESCO Finland
Hemofiltration
3.7
6.7
27
74
N06AA09
ATC
amitriptyline; systemic
1.5
6.6
232
1600
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
5.2
6.6
19
37
H11.3
ICD-10 Finland
Conjunctival haemorrhage
1.9
6.6
89
471
QAA99
NOMESCO Finland
Other local destruction of skin of head or neck
7.8
6.6
14
18
N04.0
ICD-10 Finland
Nephrotic syndrome, minor glomerular abnormality
7.8
6.6
14
18
A01
ICPC
Pain general/multiple sites
1.5
6.6
195
1297
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.3
6.6
59
264
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.6
6.6
156
982
NG1DA
NOMESCO Finland
X-ray of knees
2.5
6.6
47
188
N03.1
ICD-10 Finland
Chronic nephritic syndrome, focal and segmental glomerular lesions
12.3
6.6
11
9
WX610
NOMESCO Finland
Patient controlled analgesia
3.5
6.6
28
80
L40.8
ICD-10 Finland
Other psoriasis
3.5
6.6
28
80
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.2
6.6
31
96
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
3.6
6.6
27
75
XG410
NOMESCO Finland
Flow-volume spirometry
1.8
6.5
110
630
XPX04
NOMESCO Finland
Angioscopy
4.3
6.5
22
51
S01XA18
ATC
ciclosporin; ophthalmic
4.8
6.5
20
42
L04AA32
ATC
apremilast; oral
6.8
6.5
15
22
M65.3
ICD-10 Finland
Trigger finger
1.8
6.5
106
602
A07EA02
ATC
hydrocortisone; rectal
2.1
6.5
66
313
M02AA07
ATC
piroxicam; topical
1.2
6.5
920
7837
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
1.7
6.5
132
800
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
6.2
6.5
16
26
H01
ICPC
Ear pain/earache
1.4
6.5
331
2455
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.4
96
529
H3602, E103
ICD-10 Finland
NA
5.7
6.4
17
30
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.2
6.4
63
293
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.4
6.4
384
2920
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.2
6.4
58
261
5672A
ICD-9 Finland
Peritonitis, Other suppurative peritonitis[PERITONITIS SUPPURATIVA DIFFUSA]
70.0
6.4
7
*
R4190
NOMESCO Finland
Nutritional therapy
1.8
6.4
109
627
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
6.4
300
2193
D09AB01
ATC
zinc bandage without supplements; topical
2.3
6.4
53
230
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.1
6.4
70
342
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.1
6.4
70
342
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
2.8
6.4
38
137
JAL10
NOMESCO Finland
Laparotomy and removal of foreign body
14.3
6.4
10
7
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
6.4
444
3459
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.0
6.4
34
115
D23.6
ICD-10 Finland
Benign neoplasm: Skin of upper limb, including shoulder
3.5
6.4
27
77
D01AC02
ATC
miconazole; topical
1.5
6.4
191
1278
H66.9
ICD-10 Finland
Otitis media, unspecified
1.5
6.4
201
1357
M01AE02
ATC
naproxen; oral, rectal
1.2
6.4
1819
16566
WX290
NOMESCO Finland
Other blockade of nerve
1.2
6.3
1510
13525
5BA08
NOMESCO Finland
NA
4.4
6.3
21
48
D11A
ATC
OTHER DERMATOLOGICAL PREPARATIONS
6.5
6.3
15
23
D20
ICPC
Mouth/tongue/lip symptom/complaint
1.7
6.3
122
728
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
6.3
120
711
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.2
6.3
60
277
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
2.7
6.3
39
145
R06AE09
ATC
levocetirizine; oral
1.3
6.3
440
3430
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
6.3
161
1035
K29.7
ICD-10 Finland
Gastritis, unspecified
1.9
6.3
83
439
H28.0*E10.3
ICD-10 Finland
Other specified diabetes mellitus - Diabetic cataract
5.9
6.3
16
27
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
11.0
6.3
11
10
134
Kela drug reimbursment
General erythroderma
5.5
6.3
17
31
M07.3*L40.5
ICD-10 Finland
Other psoriatic arthropathies
2.2
6.3
60
278
J45
ICD-10 Finland
Asthma
1.4
6.3
256
1825
TK824
NOMESCO Finland
Replacement of peritoneal dialysis catheter extension tube
9.3
6.3
12
13
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
6.3
991
8531
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.6
6.3
42
163
2505B
ICD-9 Finland
Diabetes mellitus, Diabetes with ophthalmic manifestations[NEUROPATHIA DIABETICA,TYYPPI I]
18.0
6.3
9
5
5900A
ICD-9 Finland
Infections of kidney, Chronic pyelonephritis
18.0
6.3
9
5
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.4
6.3
51
218
Q44.20
ICD-10 Finland
Atresia of intrahepatic bile ducts
+∞
6.2
6
*
Q44.29
ICD-10 Finland
Atresia of bile ducts
+∞
6.2
6
*
5244
FHL
Heart transplantation
+∞
6.2
6
*
0539X
ICD-9 Finland
Herpes zoster without mention of complication
+∞
6.2
6
*
Q60.4
ICD-10 Finland
Renal hypoplasia, bilateral
+∞
6.2
6
*
G04BD12
ATC
mirabegron; oral
1.5
6.2
213
1466
PB1AT
NOMESCO Finland
Upper extremity artery PTA
26.7
6.2
8
*
C03BA08
ATC
metolazone; oral
26.7
6.2
8
*
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.8
6.2
19
40
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
4.8
6.2
19
40
SPAT1097
SPAT
Recording of ECG
1.4
6.2
338
2536
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.2
6.2
59
272
R04.0
ICD-10 Finland
Epistaxis
1.6
6.2
152
967
C02DE10
ATC
NA
3.4
6.2
27
79
H92.0
ICD-10 Finland
Otalgia
1.6
6.2
152
968
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.4
6.2
238
1678
H16.0
ICD-10 Finland
Corneal ulcer
1.7
6.2
126
765
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
2.4
6.2
49
209
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
6.2
434
3387
C01DA14
ATC
isosorbide mononitrate; oral
1.4
6.2
246
1745
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
6.2
440
3438
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
1.6
6.1
161
1044
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
6.1
148
937
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
6.1
140
876
SPAT1252
SPAT
Overall medication plan or its review
1.6
6.1
156
1004
RK110
NOMESCO Finland
NA
3.4
6.1
27
80
V03AE04
ATC
calcium acetate and magnesium carbonate; systemic
12.5
6.1
10
8
R06.5
ICD-10 Finland
Mouth breathing
1.4
6.1
235
1658
R01AC02
ATC
levocabastine; nasal
1.9
6.1
85
460
ND1AA
NOMESCO Finland
Wrist X-ray examination
1.6
6.0
152
973
CKC10
NOMESCO Finland
Local photocoagulation of retina
2.5
6.0
44
179
M70.6
ICD-10 Finland
Trochanteric bursitis
1.4
6.0
265
1916
BBA40
NOMESCO Finland
Subtotal parathyroidectomy
4.4
6.0
20
46
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
10.0
6.0
11
11
WX203
NOMESCO Finland
Infraclavicular plexus blockade
2.1
6.0
63
305
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3010375) cycloSPORINE [Mass/volume] in Blood
248
133
19.76
316.76
31.8
24.9
ug/l
101.8
125.8
3.14
223
109
(3026250) Tacrolimus [Mass/volume] in Blood
181
147
12.82
184.75
43.8
35.3
ug/l
6.7
7.5
4.13
164
133
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
333
642
5.55
165.26
11.1
5.7
iu/ml
742.4
1008.8
0.22
66
93
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
283
490
6.12
157.24
6.8
3.1
u/ml
272.8
1454.8
0.89
25
33
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
86
58
15.12
97.39
5.4
7.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
2385
16954
1.95
93.31
10.4
5.9
e9/l
0.0
0.0
0.63
2198
14695
(3001604) Monocytes [#/volume] in Blood
2376
16903
1.94
92.35
10.5
5.9
e9/l
0.6
0.6
1.34
2193
14652
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
321
945
3.60
91.45
11.8
5.2
mg/l
1.8
1.4
10.40
303
883
(3003458) Phosphate [Moles/volume] in Serum or Plasma
820
3991
2.31
90.46
17.0
6.0
mmol/l
1.1
1.1
4.02
798
3731
(3019198) Lymphocytes [#/volume] in Blood
2428
17520
1.92
89.01
10.4
5.9
e9/l
1.9
2.0
0.92
2256
15498
(3013115) Eosinophils [#/volume] in Blood
2425
17570
1.90
86.90
10.8
6.1
e9/l
0.2
0.2
0.29
2256
15471
(3020779) Urea [Moles/volume] in Serum or Plasma
603
2645
2.50
83.54
20.5
7.9
mmol/l
10.8
8.7
11.36
593
2540
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
525
2206
2.58
79.41
8.8
4.0
ng/l
117.1
82.8
6.38
473
1945
(3024561) Albumin [Mass/volume] in Serum or Plasma
1906
13176
1.82
75.35
8.7
4.8
g/l
36.0
36.1
0.39
1802
12279
(3013650) Neutrophils [#/volume] in Blood by Automated count
2582
19562
1.83
75.20
12.9
8.8
e9/l
4.0
4.0
0.10
2391
17067
(42870588) Differential panel, method unspecified - Blood
1684
11243
1.83
74.37
9.9
5.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
101
132
7.82
72.66
2.4
1.8
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3065
24799
1.88
68.76
6.3
3.8
mm/h
12.0
10.7
5.25
2904
23084
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1934
13683
1.77
68.54
3.5
2.2
nmol/l
76.4
75.1
1.44
1810
12522
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2067
15199
1.71
61.42
14.2
6.5
mmol/l
1.2
1.2
0.16
1809
12854
(3006504) Eosinophils/100 leukocytes in Blood
2137
15908
1.70
60.22
10.7
6.0
%
2.8
2.8
0.05
2058
14853
(3019069) Monocytes/100 leukocytes in Blood
2146
16007
1.70
59.91
11.0
6.3
%
8.6
8.4
1.64
2076
15043
(3018418) pH of Serum or Plasma
1344
8872
1.76
58.17
9.2
3.8
ph
7.4
7.4
3.61
270
1702
(3022096) Basophils/100 leukocytes in Blood
2075
15415
1.69
58.16
10.9
6.1
%
0.7
0.7
0.09
2000
14431
(3002030) Lymphocytes/100 leukocytes in Blood
2201
16612
1.69
58.05
10.7
6.0
%
28.5
29.0
1.48
2121
15549
(3018010) Neutrophils/100 leukocytes in Blood
2174
16358
1.68
57.98
10.3
5.8
%
56.9
56.5
1.09
2098
15359
(3007853) Bacteria identified in Skin by Aerobe culture
710
3851
2.02
56.90
2.1
1.7
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3024
24935
1.77
56.81
11.8
7.0
u/l
77.1
77.2
0.07
2928
23530
(3009508) Creatinine [Moles/volume] in Urine
1426
9653
1.72
55.95
5.0
3.3
mmol/l
7.3
7.8
3.85
1275
8230
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
47
30
15.83
54.62
6.6
5.6
mg/l
3.1
2.5
0.48
38
22
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1881
13779
1.66
54.36
12.4
5.8
mmol/l
1.2
1.2
0.08
1763
12507
(3000850) Epithelial cells [#/volume] in Urine
1047
6640
1.77
50.88
4.7
2.5
e6/l
5.1
6.5
2.91
956
5804
(3042733) HLA Ab [Presence] in Serum
78
117
6.77
49.62
5.0
4.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1244
8330
1.70
49.51
5.1
3.3
mg/l
476.9
329.4
0.53
911
5306
(3021601) Nitrite [Presence] in Urine by Test strip
2165
16680
1.62
49.34
7.2
4.6
estimate
0.0
0.0
0.40
451
3225
(40760892) CBC W Ordered Manual Differential panel - Blood
1193
7910
1.71
49.19
7.8
4.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
768
4474
1.88
49.15
4.8
2.4
g/l
2.3
2.4
2.92
736
4137
(3035350) Ketones [Presence] in Urine by Test strip
2161
16658
1.61
49.01
5.6
3.4
estimate
0.0
0.0
1.08
431
3137
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
603
3247
2.00
48.75
5.0
4.3
u/l
231.2
243.8
1.72
579
3070
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
721
4127
1.90
48.68
5.1
2.5
%
23.2
23.5
0.23
616
3560
(3022948) Iron [Moles/volume] in Serum or Plasma
816
4865
1.84
48.45
4.8
2.4
umol/l
13.2
13.8
1.89
786
4510
(3009261) Glucose [Presence] in Urine by Test strip
2176
16837
1.61
48.30
5.5
3.4
estimate
0.0
0.0
0.32
435
3132
(3020682) Albumin/Creatinine [Ratio] in Urine
1288
8754
1.68
48.22
6.1
4.0
mg/mmol
15.4
9.4
2.84
929
5600
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
802
4768
1.84
48.01
2.3
1.8
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2717
22226
1.63
47.58
5.7
4.1
e6/l
32.7
1640.4
3.75
40
267
(3012095) Magnesium [Moles/volume] in Serum or Plasma
814
4894
1.82
46.86
7.6
3.6
mmol/l
0.8
0.8
5.32
779
4602
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
440
2145
2.17
46.29
2.0
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
591
3248
1.95
44.80
2.2
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
586
3221
1.95
44.37
2.1
1.7
—
—
—
0
0
(3015736) pH of Urine
1736
12911
1.59
44.17
5.0
3.2
—
5.7
—
0
9
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2094
16276
1.57
43.92
8.0
5.9
umol/l
10.5
11.1
1.69
2004
15396
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
72
114
6.41
43.51
3.4
2.5
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
38
25
15.33
43.40
4.2
3.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
2357
18877
1.57
42.93
7.3
4.5
mmol/l
6.7
6.6
1.39
2201
17420
(3037467) Urinalysis macro (dipstick) panel - Urine
2813
23482
1.60
42.72
6.8
4.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1180
8043
1.65
42.67
4.8
2.5
umol/l
3061.4
4309.6
0.62
1077
7076
(3012544) pH of Venous blood
538
2909
1.97
42.63
9.3
4.2
ph
7.4
7.4
—
5
11
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
478
2483
2.04
42.39
3.2
2.5
ml/min/173m2
57.9
70.9
8.68
208
930
(3017181) Myelocytes/100 leukocytes in Blood
500
2665
1.99
41.21
6.5
4.2
%
0.7
0.9
0.49
176
693
(3002032) Base excess in Venous blood by calculation
520
2824
1.96
40.58
9.8
4.2
mmol/l
1.6
1.9
0.92
427
2274
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
163
522
3.21
40.34
2.0
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1593
11800
1.56
40.12
10.7
8.0
inr
1.2
1.2
0.24
477
3553
(40768804) Tissue Pathology biopsy report
1756
13333
1.55
39.37
2.5
2.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
465
2457
2.00
39.19
5.9
4.0
%
0.6
0.6
0.04
127
513
(3023368) Bacteria identified in Blood by Culture
1141
7856
1.62
38.99
5.8
4.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
513
2837
1.92
37.79
9.6
4.2
kpa
5.7
5.9
1.74
504
2755
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
31
18
17.34
37.63
5.6
5.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
475
2576
1.95
37.05
3.7
2.7
g/l
10.0
10.5
1.44
448
2359
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
27
12
22.64
36.74
7.0
7.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1696
12937
1.52
36.31
5.7
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
193
724
2.75
36.02
2.3
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1366
9960
1.55
35.91
3.6
2.5
u/l
57.4
57.8
0.09
1279
9210
(3021440) Promyelocytes/100 leukocytes in Blood
467
2545
1.94
35.86
6.6
4.3
%
0.1
0.1
0.33
162
642
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
242
1017
2.46
35.83
2.7
1.7
g/l
1.1
1.2
1.64
235
958
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
30
18
16.78
35.82
5.3
5.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
432
2298
1.98
35.58
3.4
2.7
e9/l
70.4
70.3
0.02
344
1723
(3018095) Leukocytes [#/volume] in Urine
1540
11550
1.53
35.45
6.4
3.5
e6/l
68.0
91.6
0.59
1201
7913
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
192
725
2.73
35.39
2.6
1.5
u/ml
161.3
111.8
1.10
37
132
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
202
784
2.66
35.27
2.5
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1058
7314
1.60
34.90
5.7
3.7
kg/l
1.0
1.0
0.18
129
1109
(3027945) Reticulocytes/100 erythrocytes in Blood
549
3179
1.84
34.88
4.2
2.8
%
1.8
1.7
0.11
516
2838
(3042936) Bacteria identified in Isolate by Culture
710
4447
1.72
34.43
2.6
2.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
437
2363
1.95
34.27
8.6
3.6
kpa
5.2
4.7
3.59
432
2287
(3000494) Fungus identified in Specimen by Culture
633
3845
1.76
34.22
1.9
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1316
9609
1.54
33.95
5.8
3.1
e6/l
58.4
88.9
0.40
1122
7293
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
129
400
3.30
33.68
2.2
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1102
7750
1.57
33.55
5.4
3.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1230
8870
1.55
33.48
6.5
3.7
estimate
0.0
0.0
1.54
428
3132
(3030467) Casts [#/volume] in Urine by Automated count
1223
8811
1.55
33.43
5.7
3.0
e6/l
0.3
0.4
2.93
1023
6577
(3025159) Blasts/100 leukocytes in Blood
440
2409
1.92
33.21
6.7
4.3
%
0.0
0.4
0.97
136
541
(40761535) Cells panel - Urine sediment
453
2507
1.90
33.10
5.9
3.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
733
4676
1.69
33.09
3.0
2.3
s
29.3
29.7
0.91
709
4533
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
151
520
2.98
33.01
2.4
1.7
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
1212
8734
1.55
33.01
5.4
2.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
463
2586
1.89
32.88
12.7
8.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
230
983
2.42
32.81
2.7
1.7
g/l
0.2
0.2
2.23
223
925
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
188
730
2.65
32.80
2.3
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
126
392
3.28
32.72
2.1
1.5
—
—
—
0
0
(3026782) Osmolality of Urine
913
6176
1.61
32.66
5.3
2.6
mosm/kgh2o
517.8
553.3
5.71
811
5250
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1239
9010
1.53
32.21
2.8
2.1
u/l
230.8
225.0
0.04
1176
8515
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3779
34804
1.88
31.99
21.5
12.2
mg/l
20.8
22.3
2.12
3071
27013
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
94
248
3.85
31.32
2.3
2.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1471
11154
1.49
31.04
4.9
3.2
u/l
31.0
33.4
0.74
1402
10611
(21494815) CD4 cells/100 lymphocytes in Specimen
104
296
3.58
31.04
2.5
2.4
%
36.8
44.5
0.51
11
41
(3021589) Normoblasts [#/volume] in Blood
1909
15237
1.46
31.04
14.7
8.8
e9/l
0.0
0.0
0.02
1661
12422
(3026008) Bacteria identified in Urine by Culture
1268
9327
1.52
31.00
3.4
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
1173
8513
1.52
30.45
9.3
6.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
121
385
3.21
30.31
1.8
1.4
—
—
—
0
0
(44790047)
115
357
3.28
29.99
2.1
1.5
—
—
—
0
0
(44790049)
115
357
3.28
29.99
2.1
1.5
—
—
—
0
0
(44790048)
115
357
3.28
29.99
2.1
1.5
—
—
—
0
0
(44806118)
115
357
3.28
29.99
2.1
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1128
8140
1.53
29.98
2.8
2.2
mg/l
2.9
2.8
0.27
1009
6967
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
134
456
3.00
29.94
1.8
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1985
16041
1.45
29.80
4.2
2.8
ug/l
115.1
104.1
1.63
1899
15006
(3023103) Potassium [Moles/volume] in Serum or Plasma
3748
34562
1.81
29.75
23.2
13.6
mmol/l
4.0
3.9
2.60
3689
33576
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3066
26968
1.51
29.40
4.4
4.0
pmol/l
14.6
14.6
0.18
2854
24770
(3019550) Sodium [Moles/volume] in Serum or Plasma
3735
34454
1.78
28.96
22.7
13.5
mmol/l
139.5
139.6
3.16
3682
33545
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
201
855
2.42
28.96
2.1
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
47
73
6.50
28.96
2.0
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
190
788
2.48
28.93
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3327
29835
1.56
28.66
6.9
5.1
mmol/mol
39.9
38.8
8.12
3166
27914
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
194
816
2.44
28.65
2.2
1.3
u/ml
273.2
248.0
0.54
130
491
(3011412) CD3 cells [#/volume] in Blood
108
335
3.28
28.22
2.4
2.6
e9/l
1.2
1.2
0.31
78
192
(3004119) Hemoglobin [Mass/volume] in Venous blood
327
1711
1.99
28.05
6.9
3.3
g/l
126.5
130.6
2.28
314
1671
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
232
1068
2.24
27.85
3.2
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
77
192
4.07
27.76
2.6
2.6
%
40.4
41.6
0.13
27
66
(3036481) Cortisol [Moles/volume] in Serum or Plasma
530
3236
1.73
27.75
2.5
2.1
nmol/l
348.7
374.4
2.22
505
2971
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
92
262
3.57
27.46
1.6
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
786
5326
1.59
27.33
3.9
2.6
e6/l
0.9
1.1
0.63
535
2979
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
77
195
4.00
27.19
2.4
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
733
4902
1.60
26.91
2.3
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
711
4722
1.61
26.86
3.1
2.5
ug/g
138.1
124.9
0.43
596
3768
(3028026) IgM [Mass/volume] in Serum or Plasma
361
1993
1.89
26.38
2.4
1.8
g/l
1.5
1.3
0.39
340
1836
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
311
1634
1.98
26.34
11.3
4.7
mmol/l
24.0
24.1
0.35
280
1498
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
165
670
2.52
26.29
5.2
3.6
%
57.3
56.6
0.27
165
670
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
225
1050
2.21
26.12
2.2
2.0
ug/l
3.1
2.1
0.56
209
942
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
31
34
9.18
25.61
2.3
1.8
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
36
48
7.56
25.46
2.9
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
259
1290
2.07
25.44
1.3
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
752
5120
1.57
25.43
1.8
1.7
nmol/l
1297.6
1160.3
3.32
609
3896
(3015377) Calcium [Moles/volume] in Serum or Plasma
1348
10351
1.45
25.40
4.4
3.2
mmol/l
2.3
2.4
3.25
1216
9171
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
101
322
3.19
25.26
2.4
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
434
2584
1.76
24.71
8.9
7.3
mmol/l
1.3
1.4
1.00
422
2483
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
86
253
3.45
24.46
2.6
2.7
e6/l
744.9
723.1
0.06
20
105
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
142
558
2.60
24.22
9.3
2.8
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
280
1460
1.98
24.21
1.9
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3473
31757
1.55
24.20
5.3
4.6
mu/l
1.8
2.0
1.22
3297
29494
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
193
873
2.27
24.17
2.9
2.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1549
12288
1.41
24.03
2.0
1.9
pmol/l
98.3
96.3
0.91
847
6509
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
257
1305
2.03
23.94
6.7
2.9
%
0.7
0.7
0.06
250
1255
(3015235) Bicarbonate [Moles/volume] in Capillary blood
169
725
2.39
23.92
6.0
3.6
mmol/l
23.6
24.8
2.95
158
627
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
53
111
4.82
23.83
3.3
2.1
u/ml
424.4
27444.0
0.55
12
18
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1127
8456
1.46
23.68
1.8
1.6
mmol/l
1.4
1.4
0.32
996
7209
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1417
11096
1.42
23.54
3.9
3.2
ng/l
37.4
93.6
0.63
921
6732
(3027273) Bicarbonate [Moles/volume] in Venous blood
255
1300
2.02
23.49
6.6
3.3
mmol/l
24.9
25.2
1.02
248
1258
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
87
265
3.33
23.45
2.1
2.1
%
13.0
11.8
0.32
51
140
(3014576) Chloride [Moles/volume] in Serum or Plasma
567
3678
1.63
23.34
9.5
7.0
mmol/l
104.2
104.5
0.76
554
3597
(4010399)
381
2221
1.79
23.29
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1012
7459
1.47
23.26
3.7
3.0
ng/l
1722.6
1176.0
1.78
879
6240
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
46
87
5.33
23.22
1.3
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
54
119
4.58
22.85
1.0
1.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
259
1343
1.99
22.75
1.4
1.2
u/ml
0.6
0.9
0.31
24
112
(3019060) Gas panel - Arterial blood
324
1820
1.85
22.35
4.8
5.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
692
4754
1.55
22.20
1.5
1.3
titre
696.9
559.2
0.87
163
942
(3021960) Folate [Moles/volume] in Serum or Plasma
927
6781
1.47
21.96
1.6
1.5
nmol/l
21.4
20.4
0.98
834
5876
(3016502) Oxygen saturation in Arterial blood
460
2872
1.68
21.94
7.6
8.3
%
95.7
95.9
0.32
441
2774
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
106
380
2.84
21.63
6.0
6.7
mg/l
12.6
11.2
1.93
100
358
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
245
1268
1.99
21.63
2.1
1.9
g/l
1.5
1.5
0.34
220
1106
(3024932) HLA-DR beta [Type]
52
117
4.49
21.47
1.1
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
432
2669
1.69
21.42
7.9
8.7
g/l
120.3
122.9
1.76
417
2569
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
501
3217
1.63
21.39
7.4
7.8
kpa
5.0
5.1
0.95
474
3081
(3027801) Oxygen [Partial pressure] in Arterial blood
501
3217
1.63
21.39
7.4
7.8
kpa
12.3
12.7
1.37
474
3081
(3044889) 12 lead EKG panel
2562
22356
1.38
21.25
4.3
3.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
223
1131
2.03
20.84
5.5
3.5
g/l
0.3
0.3
0.22
148
495
(3003396) Base excess in Arterial blood by calculation
497
3207
1.62
20.77
7.4
7.8
mmol/l
1.1
1.0
0.11
385
2483
(3009343) pH of Capillary blood
339
1976
1.78
20.67
8.6
3.9
ph
7.4
7.4
0.11
58
223
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
340
1996
1.77
20.23
8.6
3.9
kpa
5.0
5.2
2.16
323
1849
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
120
475
2.57
20.22
2.4
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
114
441
2.63
20.12
1.2
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
152
672
2.31
20.12
6.0
3.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
549
3659
1.58
20.00
5.4
2.8
umol/l
6.7
7.5
0.57
480
3152
(3008152) Bicarbonate [Moles/volume] in Arterial blood
308
1762
1.81
19.99
6.6
7.2
mmol/l
24.2
24.4
0.47
288
1639
(3006245) CD3-CD19+ cells/100 cells in Blood
58
150
3.91
19.97
2.4
2.4
%
11.9
10.8
0.17
52
145
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
984
7403
1.43
19.79
2.1
1.9
mg/l
1.0
1.1
0.60
722
5518
(3002385) Erythrocyte distribution width [Ratio]
3255
29714
1.43
19.64
24.2
14.8
%
13.6
13.5
3.20
3211
29088
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3876
36728
1.74
19.62
15.7
9.4
u/l
26.1
26.5
0.91
3800
35543
(3025941) Bacteria identified in Stool by Culture
344
2052
1.74
19.34
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
98
359
2.77
19.25
1.8
1.8
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
268
1491
1.85
19.04
4.2
2.7
e6/l
0.2
0.3
0.58
262
1453
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
323
1905
1.75
18.89
8.7
3.9
mmol/l
1.3
1.6
0.78
230
1385
(3007930) Methemoglobin/Hemoglobin.total in Blood
213
1101
1.98
18.88
4.6
5.7
%
1.1
0.9
0.55
201
1028
(3037692) Legionella sp identified in Specimen by Organism specific culture
44
97
4.57
18.65
2.2
1.4
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
184
916
2.06
18.11
4.8
6.5
mmol/l
1.3
1.3
0.23
165
795
(3009445) Proteinase 3 Ab [Units/volume] in Serum
239
1303
1.88
18.09
2.6
1.5
u/ml
13.6
16.5
0.20
18
38
(3004809) Band form neutrophils/100 leukocytes in Blood
111
448
2.52
18.00
3.7
3.3
%
0.9
1.4
1.61
91
350
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3574
33360
1.49
17.78
5.1
4.0
mmol/l
4.6
4.7
8.58
3406
31300
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3612
33787
1.50
17.78
5.5
4.3
mmol/l
2.7
2.8
7.95
3432
31499
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
76
253
3.04
17.77
2.4
2.7
e6/l
537.1
550.9
0.07
64
210
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
75
248
3.06
17.74
2.4
2.8
e9/l
0.2
0.2
0.11
65
210
(40757373) Influenza virus identified in Isolate
32
56
5.75
17.56
1.9
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
27
40
6.79
17.40
14.9
8.6
mmol/l
4.7
6.4
1.73
27
40
(3041096) Erythrocytes [Presence] in Urine by Automated
1184
9366
1.37
17.31
4.9
3.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3551
33148
1.47
17.21
5.0
3.9
mmol/l
1.5
1.5
0.02
3364
30962
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
300
1783
1.74
17.06
1.7
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3440
31935
1.43
17.05
4.6
3.6
mmol/l
1.3
1.3
1.26
3240
29698
(3005322) IgE [Units/volume] in Serum or Plasma
373
2352
1.64
16.99
1.6
1.3
u/ml
595.0
203.9
0.82
348
2170
(3028626) Oxygen [Partial pressure] in Capillary blood
170
842
2.06
16.98
9.8
4.2
kpa
9.4
8.8
3.01
162
774
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
208
1108
1.92
16.90
4.6
5.7
%
1.8
1.7
0.58
196
1032
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
846
6350
1.42
16.87
1.7
1.6
pmol/l
39780965.4
37118819.0
0.05
729
5372
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1094
8588
1.37
16.67
1.4
1.3
u/ml
1.7
1.7
0.02
302
2298
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
89
335
2.69
16.64
1.4
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
691
5010
1.45
16.63
4.3
2.7
e6/l
2.5
2.9
0.61
439
2668
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
537
3702
1.52
16.63
10.3
6.2
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
117
503
2.36
16.57
4.9
3.1
—
—
—
0
0
(3020891) Body temperature
211
1137
1.90
16.56
6.7
4.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
970
7475
1.39
16.54
1.7
1.4
g/l
2.3
2.3
0.33
672
4616
(3045462) Protein/Creatinine [Ratio] in Urine
31
56
5.57
16.47
5.6
6.3
g/mol
45.6
43.2
0.05
31
48
(3000060) B lymphocytes [#/volume] in Blood
46
117
3.96
16.26
2.3
2.3
e6/l
151.4
182.5
0.38
29
64
(46235355) HIV 1 and 2 tests - Meaningful Use set
1135
8992
1.36
16.24
2.3
2.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
757
5621
1.42
15.95
1.3
1.2
u/ml
8.7
9.8
0.20
297
2260
(3039000) Anion gap in Blood
135
630
2.18
15.76
5.4
7.9
mmol/l
11.1
11.4
0.48
124
562
(3018572) Chloride [Moles/volume] in Blood
135
631
2.18
15.69
5.4
7.9
mmol/l
104.6
105.3
0.82
124
563
(3020630) Protein [Mass/volume] in Serum or Plasma
350
2216
1.63
15.67
2.5
2.6
g/l
65.4
66.9
2.83
324
2042
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
789
5920
1.41
15.64
1.3
1.3
iu/ml
27.6
29.5
0.18
261
1817
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
199
1073
1.90
15.60
3.8
3.0
g/l
3.4
3.5
0.59
191
1022
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1875
16040
1.31
15.53
4.7
3.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
112
492
2.31
15.13
1.8
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
508
3528
1.50
15.11
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
169
872
1.98
15.10
2.2
1.7
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
349
2230
1.62
15.05
3.2
2.8
ng/l
158.3
169.4
0.22
323
2007
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
83
319
2.63
14.93
1.8
1.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
261
1549
1.73
14.92
8.9
10.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
204
1126
1.85
14.88
1.6
1.6
iu/ml
0.8
0.3
0.24
39
221
(40761511) CBC panel - Blood by Automated count
3831
36577
1.56
14.07
18.8
11.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
88
366
2.43
13.48
3.4
3.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
930
7324
1.35
13.43
2.1
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
165
883
1.90
13.28
4.5
3.7
u/ml
0.3
0.3
0.55
95
495
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
17
20
8.53
13.25
3.6
4.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
127
623
2.07
13.09
1.6
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
145
749
1.97
12.96
2.3
3.5
mg/l
51.6
60.8
0.37
110
614
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
145
751
1.96
12.86
2.3
3.5
mg/l
39.7
70.9
0.96
110
616
(3006184) Hemoglobin [Mass/volume] in Capillary blood
131
655
2.03
12.83
2.8
2.3
g/l
128.4
131.3
0.65
105
487
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3433
32234
1.36
12.77
4.9
4.0
mmol/l
5.9
5.8
4.85
3224
29717
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
53
175
3.05
12.66
2.0
1.5
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
361
2421
1.54
12.61
9.0
3.4
mmol/l
1.2
1.2
1.13
329
2099
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
134
681
2.00
12.55
3.8
2.4
ug/min
185.3
110.1
0.68
85
425
(40760888) Immunoglobulin light chains.free panel - Serum
118
574
2.09
12.46
2.4
3.6
—
—
—
0
0
(3016750) Collection duration of Urine
54
183
2.98
12.34
3.7
2.1
min
508.6
497.6
0.38
46
138
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3379
31693
1.34
12.32
17.3
11.1
ml/min/173m2
84.0
86.9
8.83
2807
25770
(3004588) Protein electrophoresis panel - Serum or Plasma
279
1775
1.61
12.24
2.1
2.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
65
246
2.67
12.12
1.8
1.4
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
70
276
2.56
12.03
3.8
3.2
mu/l
21.0
28.1
0.91
70
257
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
114
556
2.08
11.97
1.9
1.5
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
13
12
10.86
11.96
5.0
3.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
184
1055
1.78
11.90
2.3
1.6
titre
454.6
300.0
0.25
14
37
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
139
730
1.94
11.87
2.2
3.5
ratio
1.3
1.5
0.46
14
61
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
438
3100
1.46
11.75
4.3
3.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
103
487
2.14
11.73
1.6
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
740
5737
1.35
11.67
4.0
3.4
ng/l
242.2
621.2
1.28
528
4048
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
34
90
3.80
11.45
2.2
1.9
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
133
697
1.94
11.44
1.5
1.4
—
—
—
0
0
(4035726)
376
2597
1.49
11.41
1.7
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4038
39258
1.80
11.38
30.2
18.0
e9/l
254.6
255.5
0.40
3988
38329
(3024731) MCV [Entitic volume]
4039
39283
1.80
11.18
30.1
17.9
fl
90.8
90.3
8.54
4016
38800
(3010813) Leukocytes [#/volume] in Blood
4040
39296
1.80
11.18
30.3
18.0
e9/l
6.8
6.7
0.81
3977
38276
(3035941) MCH [Entitic mass]
4039
39284
1.80
11.17
30.0
17.9
pg
30.3
30.2
4.86
4016
38799
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
344
2343
1.51
11.17
2.3
2.3
ug/l
6.4
7.1
0.20
313
2088
(3026361) Erythrocytes [#/volume] in Blood
4039
39291
1.79
11.06
30.2
17.9
e12/l
4.5
4.5
7.81
3979
38283
(3000963) Hemoglobin [Mass/volume] in Blood
4040
39304
1.79
11.06
30.3
18.0
g/l
135.0
136.1
5.12
4018
38817
(3003327) Ova and parasites identified in Stool by Light microscopy
212
1293
1.67
11.01
1.8
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
136
729
1.89
10.95
1.4
1.2
u/ml
48.8
47.2
0.04
21
72
(3037756) Immunofixation for Serum or Plasma
103
503
2.07
10.81
1.5
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
161
915
1.79
10.76
3.5
3.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
44
144
3.08
10.72
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
171
992
1.75
10.66
2.5
2.4
ug/l
435.4
428.2
0.01
154
925
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2814
25936
1.26
10.65
3.5
3.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1011
8285
1.29
10.62
1.7
1.6
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
168
971
1.76
10.61
1.4
1.2
u/ml
8.1
40.3
—
7
60
(40767503) Oxygen content in Capillary blood by calculation
118
613
1.95
10.44
3.5
2.4
%
16.6
16.7
0.13
81
300
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
32
88
3.66
10.23
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
128
689
1.88
10.20
1.4
1.2
u/ml
3.3
3.6
0.05
15
44
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
47
165
2.87
10.15
2.7
4.0
mg/l
7.7
7.9
0.12
35
135
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
156
895
1.77
10.12
1.4
1.2
u/ml
6.6
8.8
0.35
30
139
(3004775) Volume in Urine collected for unspecified duration
59
234
2.54
10.08
3.4
2.2
ml
750.6
618.4
1.60
48
162
(3000570) Elastase.pancreatic [Mass/mass] in Stool
156
896
1.77
10.08
1.5
1.4
ug/g
274.7
293.6
0.60
98
482
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
409
2943
1.43
10.02
3.7
2.4
g/l
0.2
0.2
0.55
388
2762
(3012501) Base excess in Blood by calculation
126
680
1.88
9.97
6.8
4.0
mmol/l
2.1
2.5
0.90
80
443
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
45
156
2.91
9.95
2.3
3.3
au/ml
162.8
96.9
—
6
25
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
45
157
2.89
9.84
3.0
2.0
umol/l
25.0
29.5
2.11
45
152
(3028271) Lactate [Moles/volume] in Capillary blood
95
467
2.06
9.83
2.1
1.8
mmol/l
1.7
1.7
0.07
95
456
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
153
883
1.76
9.74
1.4
1.2
u/ml
4.4
7.1
0.31
21
90
(3025315) Body weight
15
22
6.84
9.73
4.9
3.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
272
1821
1.53
9.59
9.6
9.6
%
93.4
94.0
0.83
272
1811
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
176
1061
1.69
9.58
3.5
3.0
%
194.5
180.3
1.20
167
1014
(3014148) Varicella zoster virus Ab [Titer] in Serum
107
555
1.95
9.55
1.1
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
63
265
2.40
9.53
2.2
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
63
265
2.40
9.53
2.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
63
265
2.40
9.53
2.2
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
86
414
2.10
9.42
1.4
1.2
u/ml
41.2
50.1
—
9
21
(3033658) Prothrombin time (PT) actual/Normal
995
8243
1.27
9.42
6.7
3.9
%
93.8
92.1
1.36
974
8027
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
38
124
3.08
9.34
5.6
3.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
41
140
2.95
9.33
1.0
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
536
4085
1.36
9.32
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
226
1464
1.57
9.24
10.3
4.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
52
203
2.58
9.21
1.3
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
43
152
2.85
9.20
1.1
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
36
115
3.15
9.18
1.3
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
670
5296
1.32
9.07
3.0
2.9
mmol/l
2.4
2.4
0.22
581
4648
(3042111) Morphology [Interpretation] in Bone marrow Narrative
87
428
2.05
9.02
1.7
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
33
101
3.29
9.01
2.4
1.4
ug/l
8.9
8.6
0.13
33
101
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
43
154
2.81
8.99
2.2
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
186
1168
1.62
8.67
3.4
2.7
%
95.9
92.4
1.13
173
1089
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
110
596
1.87
8.65
1.1
1.1
—
—
—
0
0
(4062490)
74
350
2.13
8.52
1.5
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
42
154
2.74
8.43
2.2
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
60
262
2.31
8.39
1.7
1.5
%
34.9
33.7
0.07
39
166
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
53
219
2.44
8.37
2.3
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
420
3142
1.37
8.19
1.7
1.5
—
—
—
0
0
(3010421) pH of Blood
138
814
1.72
8.19
7.0
3.9
ph
7.4
7.4
1.36
125
670
(21494814) CD8 cells/100 lymphocytes in Specimen
36
124
2.92
8.11
2.1
2.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
131
764
1.74
8.10
1.5
1.4
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
13
20
6.52
8.06
3.5
3.1
—
—
—
0
0
(3000492) Spirometry study
449
3404
1.36
8.05
1.7
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
559
4379
1.32
8.03
1.3
1.2
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
72
346
2.10
7.99
1.5
1.4
g/l
0.3
0.4
1.59
56
235
(3028192) IgG subclass 2 [Mass/volume] in Serum
72
347
2.09
7.93
1.5
1.4
g/l
2.7
3.0
0.77
56
238
(3035637) Corticotropin [Mass/volume] in Plasma
87
450
1.95
7.90
1.9
1.5
—
—
—
0
0
(3013512) EKG study
1003
8465
1.24
7.89
3.9
3.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
167
1052
1.61
7.73
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
166
1045
1.61
7.70
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
164
1030
1.62
7.68
1.3
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
71
346
2.07
7.61
1.5
1.4
g/l
6.2
6.5
0.38
54
236
(3012565) Volume of 24 hour Urine
40
152
2.65
7.53
2.2
2.5
ml
1885.5
2030.5
0.27
35
137
(3036489) Thrombin time
202
1338
1.54
7.53
3.0
2.5
s
20.8
21.5
1.67
180
1152
(3024980) IgG subclass 4 [Mass/volume] in Serum
101
561
1.82
7.40
1.7
1.7
g/l
0.7
0.7
0.26
74
425
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
231
1581
1.49
7.38
1.2
1.1
u/ml
35.7
3.1
—
7
21
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
13
22
5.92
7.37
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
88
469
1.90
7.34
1.3
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1211
10505
1.21
7.20
3.0
2.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
445
3428
1.33
7.17
25.8
21.5
inr
1.3
1.3
0.42
76
499
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
240
1668
1.47
7.11
1.7
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
321
2354
1.39
7.08
2.5
2.7
e9/l
4.2
4.1
0.29
278
1912
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
44
181
2.45
7.07
1.1
1.1
miu/ml
1797.6
1444.9
1.32
44
181
(3034891) Synovial lining cells/100 cells in Synovial fluid
36
135
2.68
6.98
1.5
1.4
%
0.5
5.8
—
10
27
(3008757) Leukocyte morphology finding [Identifier] in Blood
66
324
2.05
6.97
3.7
4.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
265
1884
1.43
6.97
1.2
1.1
titre
59.0
149.6
—
5
48
(3003181) Sodium [Moles/volume] in Urine
87
475
1.85
6.77
1.4
1.4
mmol/l
64.5
65.0
0.03
72
389
(3017354) Segmented neutrophils/100 leukocytes in Blood
59
281
2.12
6.76
2.8
3.4
%
56.5
57.7
0.12
39
183
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
41
167
2.47
6.75
11.7
6.2
u/ml
48.1
218.4
0.83
14
38
(3040151) Glucose [Moles/volume] in Capillary blood
66
329
2.02
6.70
5.2
7.5
mmol/l
7.0
7.1
0.02
57
274
(3024928) Oxygen saturation in Venous blood
111
655
1.71
6.65
8.1
3.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
117
701
1.69
6.63
1.9
1.7
e6/l
7236.6
12766.3
2.01
85
504
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
218
1510
1.47
6.59
2.5
2.3
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3237
30835
1.22
6.55
25.8
15.4
g/l
333.1
333.1
0.05
3218
30603
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
24
74
3.26
6.54
1.1
1.8
ug/l
2.2
2.0
0.18
11
38
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
165
1080
1.55
6.54
1.4
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
68
347
1.98
6.48
1.7
1.6
%
54.3
58.5
0.37
46
223
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
57
273
2.10
6.45
4.0
3.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
58
281
2.08
6.38
1.3
1.1
—
29.9
—
0
6
(3043409) Potassium [Moles/volume] in Arterial blood
137
864
1.61
6.37
5.1
4.2
mmol/l
3.9
3.9
0.13
132
809
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
137
864
1.61
6.37
3.2
2.1
mg/l
11.4
11.0
0.19
130
808
(3020393) Adenovirus Ag [Presence] in Stool
20
56
3.58
6.31
2.0
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
193
1317
1.49
6.30
10.5
4.1
mmol/l
24.2
24.7
2.14
186
1240
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
937
8025
1.22
6.21
2.9
2.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
106
632
1.69
6.15
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
106
632
1.69
6.15
1.5
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
52
246
2.13
6.10
1.0
1.1
iu/ml
9.7
10.5
—
10
68
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
60
302
2.00
5.98
1.3
1.1
u/l
68.4
59.6
0.35
48
211
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
302
2260
1.36
5.91
3.2
3.3
pmol/l
4.5
4.5
0.01
272
2025
(3025549) Creatine [Moles/time] in 24 hour Urine
11
20
5.51
5.80
1.5
1.3
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
21
65
3.24
5.72
1.6
1.4
mmol/l
-0.7
0.9
1.07
21
60
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
156
1041
1.52
5.70
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
91
532
1.73
5.70
1.6
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
15
37
4.07
5.62
1.3
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
95
565
1.70
5.60
1.5
1.7
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
337
2588
1.33
5.57
2.6
2.2
nmol/l
13.0
12.4
0.63
311
2285
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
128
822
1.57
5.57
2.4
1.3
iu/ml
11.3
13.5
—
6
15
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
33
4.25
5.55
1.4
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
35
146
2.41
5.53
2.3
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2530
23725
1.17
5.52
4.2
3.0
u/l
46.5
43.4
1.19
2400
22391
(3016650) Hepatitis A virus Ab [Presence] in Serum
99
598
1.67
5.51
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
106
655
1.63
5.41
3.7
2.9
umol/l
35.5
35.9
0.06
98
566
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
16
43
3.73
5.36
1.2
1.9
ng/l
189.6
137.9
0.34
16
43
(3042631) Mycobacterium sp identified in Specimen
65
350
1.87
5.36
3.1
3.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
36
155
2.33
5.32
1.6
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
43
200
2.16
5.30
1.7
1.5
u/l
6.3
7.6
0.51
34
170
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
763
6496
1.21
5.30
1.6
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
143
954
1.52
5.26
1.6
1.3
titre
160.6
94.6
0.74
18
81
(3019832) Treponema pallidum Ab [Presence] in Serum
653
5488
1.22
5.15
1.9
1.7
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
28
109
2.58
5.12
2.0
2.0
au/ml
174.6
136.3
—
5
12
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
349
2727
1.31
5.11
1.2
1.2
iu/ml
114.7
154.9
1.10
126
1005
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
36
158
2.29
5.11
1.6
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
196
1400
1.42
5.10
2.9
1.9
u/l
40.3
39.2
0.31
179
1273
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
43
204
2.12
5.06
1.5
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
20
65
3.09
5.06
1.3
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
54
279
1.95
5.05
3.3
2.7
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
140
944
1.50
4.92
2.0
2.4
g/l
9.9
10.3
0.37
114
810
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
1011
1.48
4.89
2.0
2.4
g/l
3.6
3.8
0.59
101
741
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
148
1012
1.48
4.86
2.0
2.4
g/l
7.2
7.3
0.59
103
775
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
205
1493
1.39
4.79
1.3
1.3
miu/ml
211.6
234.4
0.34
84
710
(3009214) Lutropin [Units/volume] in Serum or Plasma
190
1367
1.41
4.77
1.5
1.5
u/l
8.2
9.1
0.41
159
1098
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
82
491
1.68
4.77
2.7
1.7
titre
1376.0
1280.0
—
5
16
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
202
1469
1.39
4.76
10.3
10.3
mmol/l
24.0
24.3
0.62
183
1387
(3010144) Erythrocytes [#/volume] in Synovial fluid
52
272
1.92
4.72
1.5
1.4
e6/l
9671.4
82263.9
1.25
36
188
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
147
1012
1.47
4.68
2.0
2.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
328
4138
0.78
4.66
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
381
3050
1.27
4.64
1.9
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
68
390
1.76
4.62
1.5
1.5
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
109
707
1.56
4.61
3.4
2.4
umol/l
5.3
6.0
0.33
91
516
(3027923) C peptide [Moles/volume] in Serum or Plasma
38
179
2.13
4.59
2.2
1.5
nmol/l
1.2
1.3
0.23
31
145
(3045142) Bone marrow Pathology biopsy report
57
311
1.84
4.57
1.4
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
279
2149
1.32
4.56
1.6
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
68
392
1.75
4.55
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
371
2970
1.27
4.52
7.0
3.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
69
401
1.73
4.49
1.5
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
48
249
1.94
4.48
1.2
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
68
394
1.74
4.47
1.5
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
176
1265
1.41
4.47
2.3
2.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
68
395
1.73
4.44
1.5
1.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
141
976
1.46
4.39
2.4
2.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
68
397
1.72
4.37
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
49
259
1.90
4.34
1.2
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
32
144
2.23
4.33
1.3
1.1
u/l
25.8
22.6
0.16
22
108
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
38
184
2.07
4.30
1.7
1.5
u/l
7.0
5.9
0.21
22
95
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
32
145
2.22
4.27
1.3
1.1
u/l
89.8
83.8
0.21
26
113
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
49
261
1.89
4.25
1.2
1.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
379
3075
1.26
4.14
3.2
2.4
u/l
39.2
52.8
0.40
326
2637
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
12
32
3.76
4.08
1.2
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
44
230
1.92
4.05
1.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
55
311
1.78
3.97
2.2
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
25
106
2.37
3.90
1.0
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
93
607
1.54
3.88
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
27
119
2.28
3.86
1.7
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
27
119
2.28
3.86
1.7
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
157
1138
1.39
3.84
2.1
1.8
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
135
955
1.43
3.80
2.1
2.4
g/l
3.0
3.1
0.24
101
759
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
940
8368
1.16
3.78
4.4
4.5
ug/l
1.9
2.5
2.76
865
7555
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
49
273
1.80
3.74
1.4
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
138
987
1.41
3.66
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
103
2.34
3.66
3.0
2.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
192
1452
1.34
3.62
1.1
1.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
277
2202
1.28
3.62
1.3
1.3
au/ml
53.9
46.4
—
8
88
(3033705) Calcium.ionized [Moles/volume] in Venous blood
53
306
1.74
3.60
2.8
2.4
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
7
9
7.79
3.55
3.6
3.7
mmol/l
4.4
4.5
—
7
9
(3000012) Reticulocyte production index
30
145
2.08
3.46
1.3
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
297
2400
1.26
3.40
2.4
2.3
au/ml
20.2
22.6
0.20
13
153
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
19
76
2.51
3.37
1.2
1.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
45
254
1.78
3.32
1.0
1.0
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
71
453
1.58
3.32
1.3
1.2
u/l
26.2
38.7
0.68
64
390
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
13
43
3.03
3.25
1.2
1.8
mg/l
1.5
1.5
—
8
37
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
15
5.34
3.19
3.6
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
664
5831
1.16
3.17
2.2
2.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
81
539
1.51
3.16
2.0
1.7
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
450
3829
1.20
3.14
2.1
2.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
17
67
2.54
3.12
1.9
2.3
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
17
67
2.54
3.12
24.2
7.4
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
46
267
1.73
3.11
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
46
267
1.73
3.11
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
46
267
1.73
3.11
1.1
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
30
152
1.98
3.09
2.4
2.1
ug/l
2.5
3.3
0.52
25
133
(3006922) Hepatitis E virus Ab [Presence] in Serum
44
253
1.75
3.08
1.1
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
48
284
1.70
3.04
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
46
269
1.72
3.04
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
46
269
1.72
3.04
1.1
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
16
62
2.59
3.04
1.0
1.1
umol/24h
0.5
0.7
—
8
36
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
77
512
1.51
3.03
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
46
270
1.71
3.00
1.1
1.2
—
—
—
0
0
(3047185) IgG [Mass/volume] in Urine
5
5
10.01
2.98
1.0
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
245
1970
1.26
2.96
1.4
1.4
iu/l
21.5
24.3
0.79
214
1642
(21494890) Protein electrophoresis panel - 24 hour Urine
45
264
1.71
2.95
2.4
2.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
24
114
2.11
2.94
4.9
4.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
97
681
1.43
2.92
5.5
3.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
119
869
1.38
2.88
2.2
2.4
g/l
0.7
0.8
0.21
103
772
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
6
9
6.67
2.86
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3406
33177
1.14
2.86
20.3
13.0
%
39.6
40.1
3.04
2488
25569
(3008116) Ketones [Moles/volume] in Urine by Test strip
16
65
2.47
2.78
1.3
1.3
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
110
799
1.39
2.76
2.0
2.3
g/l
37.5
38.1
0.49
96
701
(40762814) Titanium [Mass/volume] in Blood
12
42
2.86
2.75
2.1
2.2
ug/l
3.6
3.1
—
6
15
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
83
574
1.46
2.73
1.1
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
189
1489
1.28
2.73
2.4
1.9
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
48
296
1.63
2.65
6.1
3.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
42
250
1.69
2.65
10.8
3.5
%
11.5
11.4
0.10
42
250
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
10
32
3.13
2.64
1.2
1.1
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
7
15
4.67
2.59
6.0
5.7
umol/l
592.1
438.4
—
7
15
(36660697) Celiac disease serology panel - Serum
367
3124
1.19
2.58
1.2
1.2
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
42
252
1.67
2.58
1.3
1.2
u/ml
28.4
52.0
—
5
11
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
170
1333
1.29
2.57
1.6
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
22
107
2.06
2.56
1.3
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
16
68
2.36
2.55
1.8
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
16
68
2.36
2.55
1.8
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
16
68
2.36
2.55
1.8
1.2
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
105
769
1.37
2.53
2.1
1.9
pmol/l
214.8
201.6
0.36
100
723
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
309
3662
0.83
2.53
1.7
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
22
108
2.04
2.51
1.6
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
26
136
1.92
2.50
2.0
2.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
26
136
1.92
2.50
2.0
2.2
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
26
136
1.92
2.50
2.0
2.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
99
722
1.38
2.46
2.1
2.4
g/l
0.0
0.0
0.49
93
673
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
51
2.55
2.44
1.4
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
10
34
2.95
2.41
1.3
1.1
—
—
—
0
0
(4268621)
59
392
1.51
2.40
2.2
2.3
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
12
5.01
2.40
1.2
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
55
360
1.53
2.40
2.5
1.4
iu/ml
51.6
25.9
—
7
22
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
716
6450
1.13
2.38
2.3
2.2
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
28
153
1.84
2.38
1.1
1.1
u/ml
1.7
8.8
0.74
15
91
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
39
236
1.66
2.35
1.1
1.2
ratio
1.1
1.0
0.63
17
84
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
52
338
1.55
2.34
1.3
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
45
284
1.59
2.30
1.1
1.1
u/ml
11.6
1.1
0.44
19
106
(3044941) Cell count panel - Synovial fluid
69
479
1.45
2.28
1.6
1.5
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
13
4.62
2.27
1.0
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
47
2.56
2.27
2.3
1.4
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
97
716
1.36
2.27
2.1
2.4
g/l
0.0
0.0
0.00
91
672
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
29
163
1.78
2.26
2.5
2.0
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
29
163
1.78
2.26
2.5
2.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
29
163
1.78
2.26
2.5
2.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
29
163
1.78
2.26
2.5
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
171
1366
1.26
2.26
1.5
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
33
193
1.72
2.26
7.1
3.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
36
217
1.66
2.21
1.2
1.2
—
—
—
0
0
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
5
9
5.56
2.21
2.8
8.8
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(44813793)
42
265
1.59
2.17
1.0
1.0
—
—
—
0
0
(3017704) Immunofixation for Urine
27
151
1.79
2.15
1.4
1.6
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
26
144
1.81
2.14
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
185
1504
1.24
2.12
5.2
3.1
—
—
—
0
0
(3004451) EKG impression Narrative
24
130
1.85
2.12
1.4
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
103
778
1.33
2.10
2.2
2.3
g/l
0.3
0.0
0.51
96
726
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
118
909
1.31
2.09
1.3
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
93
692
1.35
2.09
4.7
2.2
nmol/l
0.9
0.8
1.40
74
584
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
79
573
1.39
2.08
1.2
1.3
u/ml
2.9
4.2
1.36
37
240
(3019977) pH of Arterial blood
26
146
1.79
2.06
2.6
2.8
ph
7.4
7.4
—
8
47
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
207
2492
0.82
2.05
1.4
1.4
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
6
15
4.00
2.04
2.7
1.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
42
270
1.56
2.03
1.5
1.3
titre
290.0
186.2
0.29
11
61
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
18
90
2.00
2.00
3.1
2.2
e6/l
21548.6
23001.7
—
8
51
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
16
3.75
1.93
1.3
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
318
2749
1.17
1.92
2.9
4.1
ug/l
9.4
21.7
1.69
255
2200
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
733
6698
1.11
1.92
4.4
3.9
%
21.8
21.5
0.25
330
3002
(3013139) Helicobacter pylori Ag [Presence] in Stool
263
2239
1.19
1.91
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
16
78
2.06
1.90
1.4
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
106
1.89
1.90
1.3
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
26
150
1.74
1.90
1.6
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
26
150
1.74
1.90
1.6
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
46
307
1.50
1.90
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
90
680
1.33
1.86
1.5
1.5
nmol/l
0.5
0.4
0.21
74
545
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
40
260
1.54
1.86
1.7
1.3
u/ml
0.5
1.2
0.50
24
103
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
48
325
1.48
1.85
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
525
4715
1.13
1.85
1.5
1.5
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
47
317
1.49
1.85
1.0
1.1
mg/l
240.8
257.9
0.27
42
275
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
37
237
1.57
1.84
1.1
1.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
75
553
1.36
1.82
2.3
1.5
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
5
12
4.17
1.82
6.2
6.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
20
108
1.86
1.81
3.6
3.4
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
41
270
1.52
1.81
1.5
1.3
titre
320.0
38.8
—
5
8
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
37
238
1.56
1.81
1.1
1.0
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
48
327
1.47
1.81
1.1
1.2
mg/l
35.5
39.8
0.26
39
270
(3022621) pH of Urine by Test strip
251
2141
1.18
1.80
3.2
2.7
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
13
60
2.17
1.77
2.1
2.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
13
60
2.17
1.77
3.2
3.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
78
582
1.35
1.77
1.1
1.3
u/ml
7.4
4.4
0.43
28
198
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
138
1697
0.81
1.72
1.5
1.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
13
61
2.13
1.71
30.2
7.5
—
—
—
0
0
(3019225) pH of Specimen
336
2957
1.15
1.64
7.7
4.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
41
278
1.48
1.61
1.8
1.8
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
56
403
1.39
1.61
1.4
1.3
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
40
270
1.49
1.60
1.4
1.3
nmol/l
1.8
1.5
0.88
34
241
(4027681)
39
262
1.49
1.60
1.2
1.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
17
91
1.87
1.60
1.1
1.3
%
112.8
104.1
1.06
17
85
(3011897) Casein IgE Ab [Units/volume] in Serum
16
84
1.91
1.59
1.0
1.2
u/ml
29.5
1.2
—
5
15
(3021387) Prolactin [Units/volume] in Serum or Plasma
211
1797
1.18
1.58
1.7
1.6
mu/l
310.8
301.5
0.13
196
1617
(3006653) Thiamine [Moles/volume] in Blood
29
183
1.59
1.57
1.3
1.4
nmol/l
151.2
130.8
1.56
29
183
(3047007) Chlamydophila sp Ab [Presence] in Serum
76
578
1.32
1.55
1.2
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
23
137
1.68
1.55
2.3
2.4
mmol/l
9.8
9.5
0.16
14
105
(3013762) Body weight Measured
5
15
3.34
1.52
1.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
180
1518
1.19
1.51
1.9
2.0
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
6
21
2.86
1.50
1.3
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
6
21
2.86
1.50
1.0
1.0
—
—
—
0
0
(3001729) Color of Synovial fluid
6
21
2.86
1.50
1.5
1.6
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
16
86
1.86
1.50
1.4
1.7
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
31
466
0.66
1.50
1.5
1.7
mmol/l
7.7
7.5
0.10
14
280
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
15
79
1.90
1.49
1.9
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
401
1.38
1.49
1.2
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
16
87
1.84
1.45
1.1
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
16
3.13
1.44
9.2
5.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
12
59
2.04
1.43
1.8
1.5
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
40
278
1.44
1.42
4.9
2.8
mg/l
250.5
57.2
1.09
30
207
(4024509)
41
287
1.43
1.40
1.3
1.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
73
562
1.30
1.40
2.0
3.5
u/ml
456.5
785.1
0.25
63
525
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
20
119
1.68
1.37
1.6
1.2
—
—
—
0
0
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
6
23
2.61
1.36
1.0
1.0
u/ml
0.2
0.2
—
6
18
(3008295) Osmolality of Serum or Plasma
46
331
1.39
1.36
1.3
1.5
mosm/kgh2o
284.2
281.7
0.29
38
249
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
49
357
1.38
1.35
1.3
1.4
mmol/l
10.2
12.2
1.13
13
70
(3002523) Influenza virus A Ag [Presence] in Specimen
85
672
1.27
1.34
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
47
2.13
1.33
1.9
1.5
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
18
105
1.72
1.33
3.3
2.4
e6/l
8911.1
806.4
0.44
12
82
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
48
350
1.38
1.32
1.3
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
254
2232
1.15
1.31
2.6
2.3
u/l
6692.9
6458.3
0.03
96
876
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
130
1082
1.21
1.30
1.1
1.1
u/ml
11.9
4.5
0.73
15
153
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
129
1.63
1.29
1.1
1.1
%
94.2
92.3
—
9
64
(3003434) Protein [Mass/volume] in Pleural fluid
42
301
1.40
1.29
1.4
1.5
g/l
31.0
32.6
0.40
35
269
(4015189)
13
69
1.89
1.28
3.7
2.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
108
884
1.23
1.27
1.3
1.5
mg/l
641.1
499.7
0.36
102
838
(3030313) Adrenal Ab [Titer] in Serum
9
44
2.05
1.26
1.3
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
84
670
1.26
1.25
1.3
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
131
1559
0.84
1.25
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
131
1558
0.84
1.24
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
48
355
1.36
1.23
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
131
1.61
1.23
1.0
1.1
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
9
45
2.00
1.23
2.6
8.7
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
5
19
2.63
1.21
1.0
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
8
37
2.16
1.21
1.0
1.1
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
96
782
1.23
1.20
1.3
1.5
mmol/l
3.8
3.7
0.33
90
733
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
131
1551
0.84
1.19
1.5
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
20
125
1.60
1.17
1.1
1.2
%
89.3
88.7
—
8
62
(3001019) Free T4 and TSH panel - Serum or Plasma
191
2189
0.87
1.16
1.5
1.6
—
—
—
0
0
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
0
33
0.00
1.16
0.0
1.1
—
20.9
—
0
21
(3013336) Amino acids [Identifier] in Serum or Plasma
5
20
2.50
1.15
1.2
3.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
96
787
1.22
1.14
1.3
1.6
e6/l
23.7
27.8
0.10
74
607
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
96
787
1.22
1.14
1.4
1.6
e6/l
397.2
5817.2
0.62
82
641
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
20
126
1.59
1.14
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
21
134
1.57
1.14
2.2
2.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
44
326
1.35
1.13
1.0
1.1
—
—
—
0
0
(4198724)
14
234
0.60
1.13
2.1
3.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
132
1552
0.85
1.12
1.5
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
37
267
1.39
1.12
1.2
1.1
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
19
119
1.60
1.11
1.1
1.2
%
115.9
109.5
0.61
19
106
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
10
51
1.96
1.11
1.6
1.8
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
7
31
2.26
1.10
1.9
2.3
mg/l
1.8
3.7
—
7
31
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
51
389
1.31
1.10
1.4
1.4
pmol/l
366.6
305.8
0.67
42
304
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
14
82
1.71
1.05
1.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
9
47
1.92
1.02
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
53
412
1.29
1.01
2.1
1.5
mu/l
44.3
53.5
0.30
48
362
(3044007) Cell count panel - Peritoneal fluid
14
83
1.69
1.01
3.7
2.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
53
1.89
1.01
1.1
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
89
736
1.21
1.00
1.3
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
21
139
1.51
1.00
1.0
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
36
483
0.74
1.00
3.0
3.7
u/ml
18.9
31.1
1.72
31
471
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
22
148
1.49
0.97
1.1
1.4
—
648.2
—
0
11
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
7
36
1.95
0.97
1.4
5.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
7
36
1.95
0.97
1.0
1.1
umol/24h
1.3
1.7
—
7
36
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
15
235
0.64
0.96
1.1
1.3
—
1.5
—
0
13
(3051101) Glucose [Moles/volume] in Cord blood
7
37
1.89
0.94
1.7
6.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
37
1.89
0.94
2.1
2.6
u/field
1.6
0.6
—
7
37
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
6
27
2.22
0.93
1.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
154
1346
1.15
0.93
1.5
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
72
589
1.23
0.92
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
135
1172
1.16
0.90
1.4
1.3
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
22
151
1.46
0.90
1.4
1.3
u/l
10.6
12.2
0.28
17
137
(3043238) Trisomy 21 risk [Likelihood] in Fetus
111
1293
0.85
0.89
1.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
39
297
1.32
0.89
2.2
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
177
1.41
0.88
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
74
611
1.21
0.88
1.6
1.4
u/l
17.5
22.4
0.77
59
520
(3027035) Albumin [Mass/time] in 24 hour Urine
6
30
2.00
0.87
1.2
1.2
—
640.5
—
0
9
(40768795) Lymph node Pathology biopsy report
38
291
1.31
0.84
1.1
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
14
88
1.59
0.84
1.8
2.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
23
162
1.42
0.84
1.9
1.9
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
35
266
1.32
0.82
1.1
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
191
1712
1.12
0.81
2.5
3.0
u/ml
27.2
47.5
2.56
181
1649
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
12
73
1.65
0.81
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
12
73
1.65
0.81
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
12
73
1.65
0.81
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
12
73
1.65
0.81
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
165
1466
1.13
0.81
3.7
3.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
30
224
1.34
0.79
1.4
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
110
1266
0.87
0.78
1.5
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
32
243
1.32
0.77
1.4
1.6
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
34
1.77
0.76
1.0
1.0
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
28
0.00
0.76
0.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
87
742
1.18
0.76
1.3
1.3
ug/l
7.1
3.9
0.40
79
692
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
53
1.70
0.75
1.1
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
13
83
1.57
0.74
3.0
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
38
298
1.28
0.73
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
169
1517
1.12
0.72
1.1
1.1
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
39
1.80
0.72
1.3
1.2
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
9
57
1.58
0.71
1.1
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
516
4875
1.07
0.70
1.8
1.8
%
1.5
1.4
1.16
454
4361
(3015076) Soybean IgE Ab [Units/volume] in Serum
33
256
1.29
0.70
1.1
1.1
u/ml
0.2
3.0
—
5
42
(3047189) Immunofixation for 24 hour Urine
17
118
1.44
0.69
1.3
1.7
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
17
118
1.44
0.69
2.3
2.7
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
42
1.67
0.68
8.3
8.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
111
1260
0.88
0.68
1.5
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
150
1344
1.12
0.68
1.7
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
18
127
1.42
0.67
1.3
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
12
179
0.67
0.66
1.0
1.0
ng/l
46.7
44.6
—
7
113
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
90
782
1.15
0.65
1.7
1.8
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
113
999
1.13
0.64
2.8
3.6
u/ml
66.5
1634.0
0.92
95
850
(3009871) Measles virus Ab [Titer] in Serum
17
120
1.42
0.64
1.6
1.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
5
29
1.72
0.64
1.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
12
177
0.68
0.63
1.0
1.0
ng/l
811.4
736.4
—
7
115
(3035320) C reactive protein [Mass/volume] in Body fluid
31
243
1.28
0.62
1.8
2.2
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
22
164
1.34
0.62
3.3
2.3
ug/l
23.2
214.0
0.67
22
145
(3014599) Egg white IgE Ab [Units/volume] in Serum
36
288
1.25
0.62
1.1
1.1
u/ml
6.0
3.3
0.20
11
95
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
12
176
0.68
0.61
1.0
1.0
ng/l
349.7
308.2
—
7
115
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
52
1.54
0.59
1.1
1.0
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3048879) Bone marrow aspiration report
11
72
1.53
0.59
2.1
2.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
157
1.34
0.59
1.8
2.6
umol/l
245.6
140.6
0.26
11
89
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
1.5
—
18.1
—
0
23
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
53
1.51
0.58
1.1
1.0
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
55
1.46
0.56
1.1
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
37
1.62
0.55
1.2
1.1
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
6
37
1.62
0.55
1.2
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
90
1.45
0.55
3.3
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
13
90
1.45
0.55
3.3
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
89
785
1.14
0.55
1.5
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
9
60
1.50
0.54
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
46
545
0.84
0.53
1.4
1.4
mmol/l
6.9
7.0
0.09
31
388
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
16
215
0.74
0.52
5.2
6.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
72
629
1.15
0.52
1.2
1.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
12
83
1.45
0.51
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
30
242
1.24
0.50
1.6
1.5
—
—
—
0
0
(4094501)
94
839
1.12
0.50
1.1
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
35
288
1.22
0.50
1.4
1.4
e6/l
1610.3
2392.7
0.70
23
214
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
34
279
1.22
0.50
1.6
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
67
1.49
0.49
1.1
1.1
—
—
—
0
0
(44806071)
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
16
119
1.35
0.48
1.3
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
64
559
1.15
0.47
1.1
1.1
%
116.9
117.3
0.04
59
502
(3036071) Salmonella sp Ab [Titer] in Serum
18
137
1.32
0.47
1.3
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
13
177
0.73
0.47
1.0
1.3
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
105
948
1.11
0.47
1.2
1.1
u/ml
0.9
2.1
1.74
42
412
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
16
120
1.33
0.46
1.1
1.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
36
301
1.20
0.45
1.3
1.4
promille
1.5
1.2
0.59
29
236
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
20
156
1.28
0.45
3.5
2.9
ug/l
1.4
1.4
0.03
20
143
(4211845)
21
165
1.27
0.45
1.8
3.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
86
771
1.12
0.44
2.5
2.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
69
1.45
0.44
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
43
367
1.17
0.44
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
229
1.22
0.43
2.0
2.1
u/field
2.8
2.1
0.39
18
108
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
42
359
1.17
0.42
1.8
2.1
mg/l
13.0
23.2
2.19
15
96
(40765096) Chromosome analysis panel by Banding
12
87
1.38
0.42
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
57
1.40
0.42
1.1
1.1
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
6
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
7
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
185
1976
0.93
0.40
1.5
1.4
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
12
88
1.36
0.40
1.0
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
292
0.82
0.39
1.3
1.4
pmol/l
49.6
158.5
0.57
13
95
(3014891) Appearance of Pleural fluid
5
35
1.43
0.39
2.4
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
69
617
1.12
0.39
1.1
1.2
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
5
37
1.35
0.37
2.0
3.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
72
1.39
0.36
1.2
1.2
—
—
—
0
0
(3036603) Volume of Urine
24
199
1.21
0.35
2.1
1.5
ml
1469.7
2061.0
—
7
36
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
301
1.16
0.35
1.4
1.6
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
27
227
1.19
0.34
1.0
1.1
u/l
1.1
1.1
0.25
14
107
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
25
209
1.20
0.34
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
10
133
0.75
0.33
1.0
1.0
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
49
435
1.13
0.32
3.0
3.1
nmol/l
0.7
0.8
2.86
37
331
(4133840)
7
97
0.72
0.30
1.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
163
0.80
0.29
1.3
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
148
1.22
0.29
1.9
3.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
67
733
0.91
0.29
1.2
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
178
1689
1.06
0.28
2.1
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
121
1.24
0.28
1.7
1.3
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
46
412
1.12
0.28
1.1
1.1
%
90.2
96.3
0.64
41
386
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
62
1.29
0.28
1.1
1.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
8
63
1.27
0.27
3.4
2.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
61
556
1.10
0.27
1.1
1.0
u/ml
0.3
0.5
0.24
18
143
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
24
205
1.17
0.27
1.3
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
28
321
0.87
0.26
1.1
1.2
—
—
—
0
0
(4306422)
63
578
1.09
0.25
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
9
74
1.22
0.25
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
290
3006
0.96
0.25
1.6
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
71
657
1.08
0.24
1.1
1.1
u/ml
6.5
3.7
0.31
24
262
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
9
77
1.17
0.24
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
76
708
1.07
0.22
1.5
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1260
12770
0.98
0.22
2.9
2.5
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
22
253
0.87
0.22
1.2
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
40
1.25
0.22
1.4
2.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
42
381
1.10
0.22
1.3
1.7
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
41
1.22
0.22
2.0
3.1
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
4252.0
—
0
5
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
410.2
—
0
10
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
477
4884
0.97
0.21
2.6
2.8
ug/l
0.6
0.7
2.71
290
3049
(40768800) Prostate Pathology biopsy report
43
471
0.91
0.21
1.2
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
43
1.16
0.21
2.4
3.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
15
126
1.19
0.21
1.3
1.4
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
28
249
1.13
0.20
1.5
1.6
—
—
—
0
0
(40758358) Immune stain study
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
49
1.22
0.20
1.0
1.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
50
1.20
0.19
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
85
802
1.06
0.19
1.1
1.1
u/ml
2.4
2.5
0.03
21
210
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
24
213
1.13
0.18
1.2
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
67
714
0.94
0.18
1.2
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
221
2139
1.04
0.18
2.0
2.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
12
100
1.20
0.18
1.5
1.5
—
—
—
0
0
(4034850)
108
1029
1.05
0.18
14.9
8.6
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
87
824
1.06
0.18
1.1
1.1
u/ml
1.2
1.3
0.09
34
384
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
60
1.17
0.17
7.3
3.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
61
1.15
0.17
1.3
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
121
1158
1.05
0.17
1.5
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
222
2152
1.03
0.17
1.9
2.1
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
68
0.74
0.17
1.0
1.4
—
—
—
0
0
(44806420)
5
68
0.74
0.17
2.0
2.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
22
246
0.89
0.16
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
90
857
1.05
0.16
1.1
1.1
u/ml
6.3
6.2
0.02
43
471
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
77
0.78
0.15
1.0
1.4
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
6
80
0.75
0.15
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
222
2158
1.03
0.15
2.0
2.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1072
10835
0.99
0.15
1.6
1.6
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
29
265
1.09
0.14
1.6
1.9
mmol/l
6.9
6.5
0.27
22
194
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
62
586
1.06
0.14
1.1
1.1
u/ml
5.1
2.9
0.59
25
287
(3016879) Cocaine [Presence] in Urine
205
1993
1.03
0.14
2.0
2.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
98
0.82
0.13
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
228
2223
1.03
0.13
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
94
902
1.04
0.13
1.9
2.0
iu/l
4.0
4.4
0.25
36
334
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
9
107
0.84
0.13
1.2
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
11
127
0.87
0.12
3.1
2.9
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
11
127
0.87
0.12
6.2
5.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
42
395
1.06
0.12
1.4
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
172
1.11
0.11
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
155
1511
1.03
0.10
2.0
1.7
mg/l
5.4
3.9
0.45
108
1031
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
62
594
1.04
0.10
1.0
1.1
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
5
44
1.14
0.10
1.2
1.2
—
31.8
—
0
10
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
5
44
1.14
0.10
1.2
1.2
—
24.9
—
0
10
(3017569) Oxygen content in Arterial blood
15
135
1.11
0.09
2.0
2.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
47
1.06
0.09
1.0
1.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
216
2119
1.02
0.09
2.0
2.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
48
1.04
0.09
1.6
1.6
—
—
—
0
0
(4281824)
30
319
0.94
0.09
1.1
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
16
175
0.91
0.08
1.1
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
63
607
1.04
0.08
1.1
1.1
u/ml
5.8
5.1
0.10
25
258
(40758292) HTLV I+II Ab panel - Serum
5
62
0.81
0.08
1.2
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
5
64
0.78
0.08
1.0
1.0
u/ml
0.0
1.0
—
5
36
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
65
0.77
0.08
1.0
1.1
u/ml
0.0
1.3
—
5
50
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
10
88
1.14
0.08
1.6
1.7
nmol/l
0.3
0.2
—
10
62
(3012441) Differential panel - Pleural fluid
25
234
1.07
0.08
1.5
1.4
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
6
72
0.83
0.07
1.7
1.4
%
14.6
30.2
—
6
67
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
144
1469
0.98
0.07
1.5
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
23
216
1.07
0.06
1.3
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
93
0.86
0.06
2.1
2.1
umol/l
14.5
16.5
—
8
93
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
102
0.88
0.06
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
104
0.87
0.06
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
14
152
0.92
0.06
1.1
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
63
613
1.03
0.05
1.2
1.1
iu/ml
58.2
847.2
0.55
18
170
(3035933) Granulocytes/100 leukocytes in Blood
16
149
1.07
0.05
3.1
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
11
100
1.10
0.05
10.5
11.9
—
—
—
0
0
(4146454)
31
297
1.04
0.05
3.1
2.7
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
22
232
0.95
0.05
2.2
1.4
umol/l
65.2
68.2
—
5
23
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
426
4291
0.99
0.05
1.7
1.8
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
209
1.05
0.04
1.7
1.8
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
11
101
1.09
0.04
1.1
1.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
15
141
1.06
0.03
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
69
677
1.02
0.03
4.0
3.4
mg/l
22.2
24.4
0.26
44
417
(3028707) Methadone [Presence] in Urine by Screen method
95
939
1.01
0.02
2.6
3.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
132
1332
0.99
0.02
1.8
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
376
3744
1.00
0.02
4.8
4.1
%
32.9
32.0
0.88
298
2595
(3028308) Erythrocytes [#/volume] in Pleural fluid
26
252
1.03
0.02
1.4
1.4
e6/l
417810.0
97452.8
0.34
11
159
(3023410) Appearance of Cerebral spinal fluid
36
368
0.98
0.01
1.5
2.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
15
157
0.96
0.01
2.9
3.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
37
363
1.02
0.01
3.2
4.4
u/ml
53.3
70.2
0.24
11
102
(3043410) Blood group antigens tested for on Red Blood Cells
10
106
0.94
0.01
1.8
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
29
284
1.02
0.00
1.7
3.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
15
148
1.01
0.00
2.1
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
75
748
1.00
0.00
1.2
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
149
1485
1.00
0.00
2.1
1.9
—
—
—
0
0
(3034426) Prothrombin time (PT)
13
134
0.97
0.00
1.3
1.3
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
184
0.98
0.00
1.3
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
101
0.99
0.00
1.1
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
58
579
1.00
0.00
1.5
1.6
—
—
—
0
0
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
9
0.00
0.00
0.0
1.2
—
40.2
—
0
9
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
57
0.88
0.00
1.0
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.0
u/ml
0.1
0.7
—
5
35
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
6
63
0.95
0.00
1.0
1.0
u/ml
0.5
0.1
—
6
39
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
15.4
—
0
6
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
5
53
0.94
0.00
2.0
2.2
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
2.0
—
0
7
(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
50
1.00
0.00
1.6
2.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
69
1.01
0.00
1.0
1.1
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.2
—
119.1
—
0
6
Mortality – FinRegistry
↥Association
Association between endpoint AB1_VIRAL_WARTS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_WARTS | 1.202 [1.07, 1.35] | 0.002 |
| Birth year | 0.995 [0.99, 1.0] | 0.243 |
During the follow-up period (1.1.1998 — 31.12.2019), 1093 out of 14218 females with AB1_VIRAL_WARTS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| AB1_VIRAL_WARTS | 1.296 [1.15, 1.46] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.023 |
During the follow-up period (1.1.1998 — 31.12.2019), 1218 out of 11183 males with AB1_VIRAL_WARTS died.
Mortality risk
Mortality risk for people of age
years, who have AB1_VIRAL_WARTS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.114% | 0.326% |
| 5 | 0.778% | 1.597% |
| 10 | 1.725% | 3.805% |
| 15 | 3.462% | 7.096% |
| 20 | 6.028% | 12.467% |
Relationships between endpoints
↥Index endpoint: AB1_VIRAL_WARTS – Viral warts
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data